Annotation Detail for NFKB1
Basic Information Top
| Gene Symbol: | NFKB1 ( DKFZp686C01211,EBP-1,KBF1,MGC54151,NF-kappa-B,NF-kappaB,NFKB-p105,NFKB-p50,p105,p50 ) |
|---|---|
| Gene Full Name: | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
| Band: | 4q24 |
| Quick Links | Entrez ID:4790; OMIM: 164011; Uniprot ID:NFKB1_HUMAN; ENSEMBL ID: ENSG00000109320; HGNC ID: 7794 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa04920 | Adipocytokine signaling pathway |
| hsa05160 | Hepatitis C |
| hsa04010 | MAPK signaling pathway |
| hsa05142 | Chagas disease |
| hsa05140 | Leishmaniasis |
| hsa05146 | Amoebiasis |
| hsa05145 | Toxoplasmosis |
| hsa05120 | Epithelial cell signaling in Helicobacter pylori infection |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04621 | NOD-like receptor signaling pathway |
| hsa04622 | RIG-I-like receptor signaling pathway |
| hsa04623 | Cytosolic DNA-sensing pathway |
| hsa05131 | Shigellosis |
| hsa04722 | Neurotrophin signaling pathway |
| hsa05222 | Small cell lung cancer |
| hsa05221 | Acute myeloid leukemia |
| hsa05220 | Chronic myeloid leukemia |
| hsa05212 | Pancreatic cancer |
| hsa05215 | Prostate cancer |
| hsa04062 | Chemokine signaling pathway |
| hsa04210 | Apoptosis |
| hsa05200 | Pathways in cancer |
| hsa04660 | T cell receptor signaling pathway |
| hsa04662 | B cell receptor signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| Signalling by NGF | |
| Signaling in Immune system |
| Pathway ID | Pathway Name |
|---|---|
| 200034 | IL12-mediated signaling events |
| 200037 | Alternative NF-kappaB pathway |
| 200031 | CD40/CD40L signaling |
| 200070 | Signaling events mediated by HDAC Class I |
| 200003 | Fc-epsilon receptor I signaling in mast cells |
| 200005 | BCR signaling pathway |
| 200131 | IL23-mediated signaling events |
| 200133 | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 200157 | EPO signaling pathway |
| 200017 | Atypical NF-kappaB pathway |
| 200086 | TNF receptor signaling pathway |
| 200099 | IL2 signaling events mediated by PI3K |
| 200072 | Regulation of Telomerase |
| 200075 | IL1-mediated signaling events |
| 200077 | Glucocorticoid receptor regulatory network |
| 200011 | LPA receptor mediated events |
| 200042 | Osteopontin-mediated events |
| 200108 | amb2 Integrin signaling |
| 200026 | Canonical NF-kappaB pathway |
| 200100 | Ceramide signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| P00053 | T cell activation |
| P00006 | Apoptosis signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| 500482 | Downstream TCR signaling |
| 500620 | Regulated proteolysis of p75NTR |
| 500490 | Interleukin-1 signaling |
| 500615 | NF-kB is activated and signals survival |
| No data |
| No data |
| Desease Name |
|---|
| diabetes, type 1 |
| Multiple Myeloma |
| melanoma |
| CANCER |
| ulcerative colitis |
| inflammatory bowel disease |
| IMMUNE |
| Arthritis, Psoriatic |
| sarcoidosis |
| No data |
| No data |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt results in increased activity of NFKB1 protein | increases activity | 17395010 |
| C038983 | 1,3-dimethylthiourea | 1,3-dimethylthiourea inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | 1,4-phenylenebis(methylene)selenocyanate results in decreased expression of NFKB1 mRNA | decreases expression | 16399772 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in decreased localization of NFKB1 protein | decreases localization | 16299251 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [Doxorubicin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| C118559 | 1-bromopropane | 1-bromopropane inhibits the reaction [IL1B protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16815550 |
| C118559 | 1-bromopropane | 1-bromopropane inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16815550 |
| C118559 | 1-bromopropane | 1-bromopropane inhibits the reaction [IL1B protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16815550 |
| C118559 | 1-bromopropane | 1-bromopropane inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16815550 |
| C118559 | 1-bromopropane | 1-bromopropane results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 18164123 |
| C118559 | 1-bromopropane | MAPK1 protein affects the reaction [1-bromopropane results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects reaction|increases activity | 18164123 |
| C118559 | 1-bromopropane | MAPK3 protein affects the reaction [1-bromopropane results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects reaction|increases activity | 18164123 |
| C032668 | 1-nitropyrene | 1-nitropyrene results in increased activity of NFKB1 protein | increases activity | 12393170 |
| C032668 | 1-nitropyrene | NFKBIA protein inhibits the reaction [1-nitropyrene results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 12393170 |
| C417207 | 2,2',4,6,6'-pentachlorobiphenyl | 2,2',4,6,6'-pentachlorobiphenyl results in increased activity of NFKB1 protein | increases activity | 16611624 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | NFKB1 protein results in increased susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl | increases response to substance | 18644402 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16256798 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[NFKB1 protein binds to RELA protein] which results in increased expression of ABCB1B mRNA] | affects binding|decreases reaction|increases expression | 18006147 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ozone results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18207479 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of NFKB1 mRNA | affects expression | 21346803 |
| C012177 | 2-aminofluorene | [Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of NFKB1 mRNA | affects cotreatment|increases expression | 20492335 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased activity of NFKB1 protein | increases activity | 12717745 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile results in decreased activity of NFKB1 protein | decreases activity | 16173963 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 12893773 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15772366 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of NFKB1 mRNA | decreases expression | 12419474 |
| C014036 | 4-hydroxyestradiol-17 beta | 4-hydroxyestradiol-17 beta results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 15901486 |
| C017572 | 4-nitrotoluene | 4-nitrotoluene promotes the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | increases activity|increases reaction | 17015962 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein | increases activity | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA | increases expression | 16835749 16582591 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 18508827 |
| C080417 | 4-octylphenol | 4-octylphenol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| C056369 | 5-(N-methyl-N-isobutyl)amiloride | 5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C072876 | A 771726 | A 771726 inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| C072876 | A 771726 | A 771726 inhibits the reaction [TNF protein results in increased expression of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases expression | 9973483 |
| C072876 | A 771726 | Ceramides inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| C072876 | A 771726 | Hydrogen Peroxide inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| C072876 | A 771726 | Lipopolysaccharides inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| C072876 | A 771726 | Okadaic Acid inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| C072876 | A 771726 | Tetradecanoylphorbol Acetate inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased activity of [RELA protein binds to NFKB1 protein] | affects binding|increases activity | 10799556 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 17952619 |
| D000079 | Acetaldehyde | Pentoxifylline inhibits the reaction [Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 17952619 |
| D000079 | Acetaldehyde | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 17952619 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NFKB1 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | NFKB1 protein affects the susceptibility to Acetaminophen | affects response to substance | 16081117 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of NFKB1 mRNA | affects expression | 16701773 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Disulfiram results in decreased activity of NFKB1 protein] | decreases activity|decreases reaction | 10661865 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased activity of NFKB1 protein] | decreases activity|decreases reaction | 10661865 |
| D000171 | Acrolein | Acrolein inhibits the reaction [NFKB1 protein binds to IL2 promoter] | affects binding|decreases reaction | 17491020 |
| D000171 | Acrolein | Acrolein inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15650393 |
| D000171 | Acrolein | Acrolein results in decreased activity of NFKB1 protein | decreases activity | 15650393 |
| D000171 | Acrolein | Acrolein results in increased alkylation of and results in decreased activity of NFKB1 protein | decreases activity|increases alkylation | 17491020 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Oxygen deficiency promotes the reaction [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases reaction | 17671207 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Oxygen deficiency promotes the reaction [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases reaction | 17671207 |
| C000188 | alachlor | alachlor inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 15907790 |
| C000188 | alachlor | alachlor inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Lindane results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15025948 |
| C041524 | aluminum sulfate | aluminum sulfate results in increased expression of NFKB1 mRNA | increases expression | 15961160 |
| D000584 | Amiloride | Amiloride inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 12065299 |
| D000584 | Amiloride | Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NFKB1 mRNA | affects expression | 16483693 |
| D047310 | Apigenin | Apigenin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| D001151 | Arsenic | Arsenic results in decreased expression of NFKB1 mRNA | decreases expression | 19945496 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of NFKB1 mRNA | decreases expression | 20458559 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of NFKB1 protein | decreases expression | 18349030 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of NFKB1 mRNA | increases expression | 15073043 |
| C015001 | arsenite | arsenite results in increased activity of [NFKB1 protein binds to RELB protein] | affects binding|increases activity | 18418899 |
| C015001 | arsenite | [arsenite results in increased activity of [NFKB1 protein binds to RELB protein]] which results in increased expression of IL8 mRNA | affects binding|increases activity|increases expression | 18418899 |
| C015001 | arsenite | [arsenite results in increased activity of [NFKB1 protein binds to RELB protein]] which results in increased expression of TNFSF13B mRNA | affects binding|increases activity|increases expression | 18418899 |
| C031327 | artemisinine | artemisinine inhibits the reaction [Simvastatin results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 18463201 |
| C031327 | artemisinine | artemisinine inhibits the reaction [Simvastatin results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 18463201 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 12162423 |
| D001241 | Aspirin | Aspirin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D001241 | Aspirin | Aspirin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| D001241 | Aspirin | Aspirin promotes the reaction [NFKB1 protein binds to SAT1 promoter] | affects binding|increases reaction | 16262603 |
| D001241 | Aspirin | Aspirin results in increased activity of NFKB1 protein | increases activity | 16262603 |
| D001241 | Aspirin | Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 11826407 |
| C088459 | B 581 | B 581 results in decreased activity of NFKB1 protein | decreases activity | 12085227 |
| D001542 | Benomyl | Benomyl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D001554 | Benzene | Benzene results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 11306435 |
| D001554 | Benzene | Benzene metabolite results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 15894107 |
| D001554 | Benzene | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of NFKB1 mRNA | affects cotreatment|decreases expression | 17905399 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of NFKB1 protein | increases activity | 12393170 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 16026644 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 11543732 |
| C020711 | beryllium sulfate | [beryllium sulfate co-treated with IFNG protein] results in increased expression of NFKB1 protein | affects cotreatment|increases expression | 10755711 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| C006780 | bisphenol A | bisphenol A inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| C400082 | bortezomib | [bortezomib co-treated with vorinostat] results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|decreases activity | 12893773 |
| C400082 | bortezomib | bortezomib promotes the reaction [Fenretinide inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | decreases reaction|increases activity|increases reaction | 16230421 |
| C400082 | bortezomib | [resveratrol co-treated with bortezomib] results in decreased activity of [RELA protein binds to NFKB1 protein] | affects binding|affects cotreatment|decreases activity | 17164350 |
| C106525 | broussochalcone A | broussochalcone A inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11286985 |
| D002038 | Bungarotoxins | Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| D002038 | Bungarotoxins | Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15713255 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of NFKB1 mRNA | decreases expression | 12419474 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of NFKB1 mRNA | increases expression | 16704919 |
| D002087 | Butyrates | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16256798 |
| D002087 | Butyrates | Butyrates results in increased activity of NFKB1 protein | increases activity | 16256798 |
| D002087 | Butyrates | Butyrates results in decreased expression of NFKB1 mRNA | decreases expression | 14674679 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 16052512 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [Zymosan results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 11259437 |
| C058819 | calphostin C | calphostin C inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| D002220 | Carbamazepine | Carbamazepine inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 15907790 |
| D012721 | Carbaryl | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the localization of and results in increased activity of NFKB1 protein | affects localization|increases activity | 16874658 |
| D002251 | Carbon Tetrachloride | NFKB1 gene mutant form results in increased susceptibility to Carbon Tetrachloride | increases response to substance | 15743782 |
| D002251 | Carbon Tetrachloride | PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of NFKB1 mRNA] | affects reaction|increases expression | 18038451 |
| D002251 | Carbon Tetrachloride | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 16874658 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of NFKB1 protein | decreases expression | 8825185 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 17429801 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of [NFKB1 protein binds to RELA protein] | affects binding|increases expression | 8825185 |
| D002258 | Carbonyl Cyanide m-Chlorophenyl Hydrazone | Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of NFKB1 protein | increases expression | 15978749 |
| C105934 | celecoxib | celecoxib inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| C105934 | celecoxib | celecoxib inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| D002518 | Ceramides | Ceramides inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| D007631 | Chlordecone | Chlordecone inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of NFKB1 mRNA | increases expression | 16934159 |
| D002725 | Chloroform | Chloroform results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 11306435 |
| D002927 | Cimetidine | Cimetidine inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 12065299 |
| D002927 | Cimetidine | Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of NFKB1 protein | decreases expression | 17486422 |
| C503589 | cis-9, trans-11-conjugated linoleic acid | cis-9, trans-11-conjugated linoleic acid affects the activity of NFKB1 protein | affects activity | 17327424 |
| D002994 | Clofibrate | Clofibrate results in increased activity of NFKB1 protein | increases activity | 10200566 |
| D003000 | Clonidine | Clonidine inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 12065299 |
| D003000 | Clonidine | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| D003042 | Cocaine | Cocaine affects the expression of NFKB1 mRNA | affects expression | 15681117 |
| D003300 | Copper | Copper results in increased activity of NFKB1 protein | increases activity | 16987042 |
| D003300 | Copper | tempol inhibits the reaction [Copper results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16987042 |
| C098468 | copper histidine | copper histidine results in increased activity of NFKB1 protein | increases activity | 16987042 |
| C098468 | copper histidine | tempol inhibits the reaction [copper histidine results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16987042 |
| D003375 | Coumestrol | Coumestrol results in decreased expression of NFKB1 protein | decreases expression | 16696175 |
| D003474 | Curcumin | Curcumin analog results in decreased activity of NFKB1 protein | decreases activity | 17041101 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides promotes the reaction [NFKB1 protein binds to IL18 promoter]] | affects binding|decreases reaction|increases reaction | 17399992 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Paclitaxel results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16243823 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16219905 15489888 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 17640567 15489888 |
| D003474 | Curcumin | Curcumin results in decreased activity of NFKB1 protein | decreases activity | 17041101 17596214 16173963 |
| D003474 | Curcumin | Curcumin results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 16023083 |
| D003474 | Curcumin | Curcumin results in decreased expression of NFKB1 protein | decreases expression | 18593936 18555241 |
| D003474 | Curcumin | Curcumin results in decreased localization of NFKB1 protein | decreases localization | 16299251 |
| D003474 | Curcumin | Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | decreases reaction|increases activity | 16219905 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | decreases reaction|increases activity | 16219905 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]] | affects binding|decreases reaction|increases activity | 17640567 |
| D003474 | Curcumin | Curcumin inhibits the reaction [NFKB1 protein binds to RELA protein] | affects binding|decreases reaction | 18752423 |
| D003474 | Curcumin | Curcumin inhibits the reaction [[NFKB1 protein binds to RELA protein] which results in increased expression of ABCB1B mRNA] | affects binding|decreases reaction|increases expression | 18006147 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 17887948 |
| D003474 | Curcumin | [Zinc binds to Curcumin] which affects the expression of NFKB1 mRNA | affects binding|affects expression | 19589337 |
| D003513 | Cycloheximide | Cycloheximide affects the localization of NFKB1 protein | affects localization | 16637064 |
| D003513 | Cycloheximide | Cycloheximide results in decreased expression of [NFKB1 protein binds to RELA protein] | affects binding|decreases expression | 16637064 |
| C110747 | cyclopropapyrroloindole | cyclopropapyrroloindole inhibits the reaction [TNF protein results in increased expression of NFKB1 protein] | decreases reaction|increases expression | 10416616 |
| D003609 | Dactinomycin | Dactinomycin results in decreased expression of NFKB1 mRNA | decreases expression | 16001973 |
| D003613 | Danazol | Danazol inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D003634 | DDT | DDT results in decreased expression of NFKB1 protein | decreases expression | 16696175 |
| C014347 | decitabine | decitabine promotes the reaction [NFKB1 protein binds to IER3 promoter] | affects binding|increases reaction | 19117987 |
| C014347 | decitabine | decitabine results in increased expression of NFKB1 mRNA | increases expression | 19027835 |
| C014347 | decitabine | decitabine results in increased expression of NFKB1 protein | increases expression | 19027835 |
| C014347 | decitabine | TNF protein promotes the reaction [decitabine promotes the reaction [NFKB1 protein binds to IER3 promoter]] | affects binding|increases reaction | 19117987 |
| C464444 | dehydroxymethylepoxyquinomicin | dehydroxymethylepoxyquinomicin results in decreased localization of NFKB1 protein | decreases localization | 15501958 |
| D003840 | Deoxycholic Acid | NFKB1 protein results in decreased susceptibility to Deoxycholic Acid | decreases response to substance | 12507930 |
| C007262 | deoxynivalenol | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15772366 |
| C007262 | deoxynivalenol | deoxynivalenol affects the localization of NFKB1 protein | affects localization | 12604842 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased activity of [NFKB1 protein binds to NFKB1 protein] | affects binding|decreases activity | 8887449 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased activity of [REL protein binds to NFKB1 protein] | affects binding|decreases activity | 8887449 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased activity of NFKB1 protein | increases activity | 15772366 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 15963473 |
| D003907 | Dexamethasone | Dexamethasone results in increased activity of NFKB1 protein | increases activity | 10200566 |
| D016190 | Carboplatin | Carboplatin results in decreased expression of NFKB1 mRNA | decreases expression | 18172885 |
| D003975 | Diazepam | Diazepam inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of NFKB1 mRNA | decreases expression | 18172885 |
| D004008 | Diclofenac | Diclofenac inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D004008 | Diclofenac | Diclofenac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| D004010 | Dicofol | Dicofol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 10531305 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 10531305 |
| C023635 | dienogest | dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D004052 | Diethylnitrosamine | CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of NFKB1 protein] | increases expression|increases reaction | 20583210 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased activity of [NFKB1 protein binds to NFKB1 protein] | affects binding|increases activity | 21159647 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of NFKB1 protein | increases expression | 20583210 |
| D004052 | Diethylnitrosamine | NFKB1 protein affects the susceptibility to [pirinixic acid co-treated with Diethylnitrosamine] | affects cotreatment|affects response to substance | 16434500 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-aminofluorene] results in increased expression of NFKB1 mRNA | affects cotreatment|increases expression | 20492335 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Sodium Selenite] results in increased expression of NFKB1 mRNA | affects cotreatment|increases expression | 20492335 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of NFKB1 protein | increases expression | 16439099 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of NFKB1 mRNA | increases expression | 15545218 |
| D004110 | Diltiazem | Diltiazem affects the localization of NFKB1 protein | affects localization | 15652234 |
| D004110 | Diltiazem | [Diltiazem co-treated with Lipopolysaccharides] affects the localization of NFKB1 protein | affects cotreatment|affects localization | 15652234 |
| D004110 | Diltiazem | Diltiazem inhibits the reaction [[NFKB1 protein binds to RELA protein] which binds to IL12A promoter] | affects binding|decreases reaction | 15652234 |
| D004110 | Diltiazem | Diltiazem inhibits the reaction [[NFKB1 protein binds to RELA protein] which binds to IL12B promoter] | affects binding|decreases reaction | 15652234 |
| D004110 | Diltiazem | Diltiazem results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 15652234 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]] | affects binding|decreases reaction|increases reaction | 14678569 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] | affects binding|decreases reaction|increases reaction | 14678569 |
| D004144 | Diosgenin | Diosgenin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16331273 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases reaction | 11950692 |
| D004221 | Disulfiram | Acetylcysteine inhibits the reaction [Disulfiram results in decreased activity of NFKB1 protein] | decreases activity|decreases reaction | 10661865 |
| D004221 | Disulfiram | Disulfiram results in decreased activity of NFKB1 protein | decreases activity | 10661865 |
| D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | decreases reaction|increases activity | 16219905 |
| D004050 | Ditiocarb | Ditiocarb inhibits the reaction [Isoflurane affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18708911 |
| D004317 | Doxorubicin | 1'-acetoxychavicol acetate inhibits the reaction [Doxorubicin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| D004317 | Doxorubicin | Doxorubicin affects the localization of NFKB1 protein | affects localization | 15870702 |
| D004317 | Doxorubicin | Doxorubicin results in increased activity of NFKB1 protein | increases activity | 15571967 |
| D004317 | Doxorubicin | Doxorubicin results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 15555623 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NFKB1 mRNA | increases expression | 16001973 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NFKB1 protein | increases expression | 17912235 |
| D004317 | Doxorubicin | Doxorubicin results in increased localization of NFKB1 protein | increases localization | 18463201 |
| D004317 | Doxorubicin | NFKB1 protein affects the reaction [Doxorubicin results in decreased expression of DDIT3 protein] | affects reaction|decreases expression | 17912235 |
| D004317 | Doxorubicin | NFKB1 protein affects the reaction [Doxorubicin results in increased expression of BCL2L1 protein] | affects reaction|increases expression | 17912235 |
| D004317 | Doxorubicin | NFKB1 protein affects the reaction [Doxorubicin results in increased expression of HIF1A protein] | affects reaction|increases expression | 17912235 |
| D004317 | Doxorubicin | NFKB1 protein affects the reaction [Doxorubicin results in increased expression of TP53 protein] | affects reaction|increases expression | 17912235 |
| D004317 | Doxorubicin | NFKB1 protein affects the reaction [Doxorubicin results in increased expression of VEGFA protein] | affects reaction|increases expression | 17912235 |
| D004317 | Doxorubicin | NFKB1 protein affects the susceptibility to Doxorubicin | affects response to substance | 17912235 |
| D004317 | Doxorubicin | [NFKB1 protein binds to RELA protein] which affects the susceptibility to Doxorubicin | affects binding|affects response to substance | 16322301 |
| D004317 | Doxorubicin | Simvastatin promotes the reaction [Doxorubicin results in increased localization of and results in increased activity of NFKB1 protein] | increases activity|increases localization|increases reaction | 18463201 |
| D004317 | Doxorubicin | Simvastatin promotes the reaction [Doxorubicin results in increased localization of NFKB1 protein] | increases localization|increases reaction | 18463201 |
| D004317 | Doxorubicin | Sirolimus inhibits the reaction [Doxorubicin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15571967 |
| D004317 | Doxorubicin | TP53 protein affects the reaction [Doxorubicin results in increased expression of NFKB1 protein] | affects reaction|increases expression | 17912235 |
| D004391 | Dust | Dust results in increased expression of NFKB1 mRNA | increases expression | 17805423 |
| D004726 | Endosulfan | [Endosulfan co-treated with Zineb] results in increased activity of NFKB1 protein | affects cotreatment|increases activity | 17189834 |
| D004726 | Endosulfan | Endosulfan results in increased activity of NFKB1 protein | increases activity | 17189834 |
| D004726 | Endosulfan | Endosulfan results in increased activity of NFKB1 protein | increases activity | 17261270 |
| D004726 | Endosulfan | [Endosulfan results in increased activity of NFKB1 protein] which results in increased expression of IL1B mRNA | increases activity|increases expression | 17261270 |
| D004726 | Endosulfan | [Endosulfan results in increased activity of NFKB1 protein] which results in increased expression of IL6 mRNA | increases activity|increases expression | 17261270 |
| D004726 | Endosulfan | [Endosulfan results in increased activity of NFKB1 protein] which results in increased expression of NOS2 mRNA | increases activity|increases expression | 17261270 |
| D004726 | Endosulfan | [Endosulfan results in increased activity of NFKB1 protein] which results in increased expression of TNF mRNA | increases activity|increases expression | 17261270 |
| C044101 | endotoxin, Escherichia coli | Paraquat promotes the reaction [endotoxin, Escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|increases reaction | 16919916 |
| C044101 | endotoxin, Escherichia coli | SB 203580 inhibits the reaction [Paraquat promotes the reaction [endotoxin, Escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]]] | affects binding|affects localization|decreases reaction|increases reaction | 16919916 |
| D004732 | Endrin | Endrin affects the activity of NFKB1 protein | affects activity | 10385688 |
| D004958 | Estradiol | Danazol inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D004958 | Estradiol | dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D004958 | Estradiol | [Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein | affects cotreatment|increases activity | 15866594 |
| D004958 | Estradiol | Estradiol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 12574206 |
| D004958 | Estradiol | Estradiol promotes the reaction [TNF protein results in increased activity of NFKB1 protein] | increases activity|increases reaction | 12574206 |
| D004958 | Estradiol | Estradiol results in increased expression of NFKB1 mRNA | increases expression | 19401270 |
| D004958 | Estradiol | Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D004958 | Estradiol | Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D000431 | Ethanol | Ethanol results in increased activity of [NFKB2 protein binds to NFKB1 protein] | affects binding|increases activity | 10573527 |
| D000431 | Ethanol | Ethanol results in increased activity of [RELA protein binds to NFKB1 protein] | affects binding|increases activity | 10573527 |
| D000431 | Ethanol | Curcumin inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 17887948 |
| D000431 | Ethanol | Ethanol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 17887948 |
| D000431 | Ethanol | Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|increases activity|increases reaction | 17887948 |
| D000431 | Ethanol | Ethanol results in decreased activity of [NFKB1 protein binds to NFKB1 protein] | affects binding|decreases activity | 17887948 |
| D000431 | Ethanol | Ethanol results in increased activity of [RELA protein binds to NFKB1 protein] | affects binding|increases activity | 17887948 |
| D000431 | Ethanol | lipostabil inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 17887948 |
| D000431 | Ethanol | lipostabil inhibits the reaction [Ethanol results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 17887948 |
| D000431 | Ethanol | puerarin inhibits the reaction [Ethanol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity | 17887948 |
| D000431 | Ethanol | puerarin inhibits the reaction [Ethanol results in decreased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases activity|decreases reaction | 17887948 |
| D000431 | Ethanol | puerarin inhibits the reaction [Ethanol results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 17887948 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 12072388 |
| C007650 | ethyl acetate | ethyl acetate results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 11306435 |
| C039614 | ethylisopropylamiloride | ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C049639 | evodiamine | evodiamine inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| C049639 | evodiamine | evodiamine inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| C049639 | evodiamine | evodiamine inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| C049639 | evodiamine | evodiamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15710601 |
| C093230 | fexofenadine | fexofenadine inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15663564 |
| D015073 | 2-Acetylaminofluorene | [RELA protein binds to NFKB1 protein] affects the reaction [2-Acetylaminofluorene results in increased expression of ABCB1 mRNA] | affects binding|affects reaction|increases expression | 11960367 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased localization of NFKB1 protein | increases localization | 17303067 |
| D015073 | 2-Acetylaminofluorene | Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 17303067 |
| D005472 | Fluorouracil | [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] affects the localization of NFKB1 protein | affects cotreatment|affects localization | 16637064 |
| D005472 | Fluorouracil | [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|decreases expression | 16637064 |
| D005472 | Fluorouracil | NFKB1 protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 15548681 |
| D005480 | Flurbiprofen | Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 11099482 |
| D005492 | Folic Acid | Folic Acid affects the expression of NFKB1 mRNA | affects expression | 16361273 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 17407152 |
| C007789 | fucoidan | fucoidan results in decreased activity of NFKB1 protein | decreases activity | 16201850 |
| C038958 | gadolinium chloride | gadolinium chloride inhibits the reaction [Lindane results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15025948 |
| C013550 | gastrin 17 | gastrin 17 results in decreased activity of NFKB1 protein | decreases activity | 15623601 |
| C419708 | gefitinib | gefitinib results in decreased expression of NFKB1 mRNA | decreases expression | 16685379 |
| D019833 | Genistein | Genistein affects the localization of NFKB1 protein | affects localization | 18431742 |
| C007845 | gingerol | gingerol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18683823 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11543732 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 11543732 |
| C063170 | Ginkgo biloba extract 761 | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 11543732 |
| C112772 | ginsenoside M1 | ginsenoside M1 results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 15802804 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 results in increased activity of NFKB1 protein | increases activity | 14534150 |
| C097367 | ginsenoside Rg3 | [ginsenoside Rg3 results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased activity of NFKB1 protein | increases activity|increases degradation|increases phosphorylation | 14534150 |
| D005912 | Gliotoxin | Gliotoxin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| D005912 | Gliotoxin | Gliotoxin results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 14527959 |
| D005947 | Glucose | Glucose results in increased expression of NFKB1 protein | increases expression | 18180316 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | decreases reaction|increases activity | 16219905 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]] | affects binding|decreases reaction|increases activity | 17640567 |
| D019695 | Glycyrrhizic Acid | [Glycyrrhizic Acid co-treated with Lipopolysaccharides] results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|increases activity | 11412311 |
| D006246 | Harmaline | Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 12065299 |
| D006246 | Harmaline | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C005499 | honokiol | honokiol analog inhibits the reaction [Lipopolysaccharides results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 19539808 |
| C005499 | honokiol | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 19539808 |
| D017313 | Fenretinide | bortezomib promotes the reaction [Fenretinide inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | decreases reaction|increases activity|increases reaction | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [pervanadate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D006861 | Hydrogen Peroxide | 1,3-dimethylthiourea inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| D006861 | Hydrogen Peroxide | 1'-acetoxychavicol acetate inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| D006861 | Hydrogen Peroxide | bisindolylmaleimide I inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| D006861 | Hydrogen Peroxide | calphostin C inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| D006861 | Hydrogen Peroxide | evodiamine inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| D006861 | Hydrogen Peroxide | Fenretinide inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of NFKB1 mRNA | decreases expression | 12419474 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein] | affects binding|increases activity | 11961005 |
| D006861 | Hydrogen Peroxide | lonafarnib inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| D006861 | Hydrogen Peroxide | pregna-4,17-diene-3,16-dione inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| D006861 | Hydrogen Peroxide | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| D006861 | Hydrogen Peroxide | zerumbone inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [NFKB1 protein binds to NFKB1 protein] | affects binding|increases reaction | 11728812 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [NFKB1 protein binds to RELA protein] | affects binding|increases reaction | 11728812 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [NFKB1 protein binds to RELB protein] | affects binding|increases reaction | 11728812 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of NFKB1 protein | increases expression | 16249388 |
| D006861 | Hydrogen Peroxide | NFKB1 protein mutant form inhibits the reaction [Hydrogen Peroxide results in increased expression of CAT mRNA] | decreases reaction|increases expression | 11728812 |
| C031927 | hydroquinone | hydroquinone results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 15894107 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 9890559 15489888 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 10602496 15489888 |
| D007052 | Ibuprofen | Ibuprofen results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 10602496 |
| C097613 | imatinib | imatinib results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 15100154 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in decreased activity of NFKB1 protein | decreases activity | 15811958 16082211 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of NFKB1 protein | decreases activity | 15579461 |
| C051890 | irinotecan | irinotecan results in increased activity of NFKB1 protein | increases activity | 18182997 |
| D007530 | Isoflurane | Ditiocarb inhibits the reaction [Isoflurane affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18708911 |
| D007530 | Isoflurane | Isoflurane affects the localization of NFKB1 protein | affects localization | 18708911 |
| D007545 | Isoproterenol | Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 15178407 |
| D007545 | Isoproterenol | pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15178407 |
| D007545 | Isoproterenol | Isoproterenol results in increased activity of NFKB1 protein | increases activity | 18487443 |
| C047382 | kamebakaurin | kamebakaurin binds to and results in decreased activity of NFKB1 protein | affects binding|decreases activity | 11877450 |
| D007854 | Lead | Lead results in decreased expression of NFKB1 protein | decreases expression | 16547843 |
| C008261 | lead acetate | lead acetate results in decreased expression of NFKB1 protein | decreases expression | 16547843 |
| C008281 | limonene | limonene results in increased expression of NFKB1 mRNA | increases expression | 12815608 |
| D001556 | Lindane | alpha-Tocopherol inhibits the reaction [Lindane results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15025948 |
| D001556 | Lindane | gadolinium chloride inhibits the reaction [Lindane results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15025948 |
| D001556 | Lindane | Lindane affects the reaction [Triiodothyronine results in increased activity of NFKB1 protein] | affects reaction|increases activity | 15019085 |
| D001556 | Lindane | Lindane results in increased activity of NFKB1 protein | increases activity | 15019085 15025948 |
| D001556 | Lindane | Lindane results in increased phosphorylation of NFKB1 protein | increases phosphorylation | 15025948 |
| C050016 | lipoarabinomannan | lipoarabinomannan results in decreased localization of and results in decreased activity of NFKB1 protein | decreases activity|decreases localization | 16263713 |
| C014643 | lipopeptidophosphoglycan | [lipopeptidophosphoglycan binds to and results in increased activity of TLR2 protein] results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 15910421 |
| C014643 | lipopeptidophosphoglycan | [lipopeptidophosphoglycan binds to and results in increased activity of TLR4 protein] results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 15910421 |
| C433788 | lipopolysaccharide, E. coli 026-B6 | lipopolysaccharide, E. coli 026-B6 results in increased expression of and results in increased activity of NFKB1 protein | increases activity|increases expression | 11437639 |
| C433788 | lipopolysaccharide, E. coli 026-B6 | Mercury inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11437639 |
| C482199 | lipopolysaccharide, E coli O55-B5 | 5-(N-methyl-N-isobutyl)amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Amiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Clonidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | ethylisopropylamiloride inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 12107048 |
| C482199 | lipopolysaccharide, E coli O55-B5 | lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein | affects localization|increases activity | 12107048 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Carbamazepine inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Diazepam inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 10700573 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Phenobarbital inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Phenytoin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Valproic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased activity of NFKB1 protein | increases activity | 18496239 |
| D008070 | Lipopolysaccharides | 1'-acetoxychavicol acetate inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| D008070 | Lipopolysaccharides | 1-bromopropane inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16815550 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides promotes the reaction [NFKB1 protein binds to IL18 promoter]] | affects binding|decreases reaction|increases reaction | 17399992 |
| D008070 | Lipopolysaccharides | Dicumarol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 10531305 |
| D008070 | Lipopolysaccharides | [Diltiazem co-treated with Lipopolysaccharides] affects the localization of NFKB1 protein | affects cotreatment|affects localization | 15652234 |
| D008070 | Lipopolysaccharides | indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15811958 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the localization of NFKB1 protein | affects localization | 15652234 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [NFKB1 protein binds to IL18 promoter] | affects binding|increases reaction | 17399992 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of NFKB1 protein | increases activity | 11739238 10531305 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 16815550 |
| D008070 | Lipopolysaccharides | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11739238 |
| D008070 | Lipopolysaccharides | Tosyllysine Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11739238 |
| D008070 | Lipopolysaccharides | 1-bromopropane inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16815550 |
| D008070 | Lipopolysaccharides | 4-nitrotoluene promotes the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | increases activity|increases reaction | 17015962 |
| D008070 | Lipopolysaccharides | 4-octylphenol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]] | affects binding|decreases reaction|increases reaction | 14678569 |
| D008070 | Lipopolysaccharides | 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] | affects binding|decreases reaction|increases reaction | 14678569 |
| D008070 | Lipopolysaccharides | alachlor inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 15907790 |
| D008070 | Lipopolysaccharides | alachlor inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Benomyl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 11543732 |
| D008070 | Lipopolysaccharides | bisphenol A inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 15907790 |
| D008070 | Lipopolysaccharides | Carbaryl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Chlordecone inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Dicofol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Flurbiprofen inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 11099482 |
| D008070 | Lipopolysaccharides | gingerol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18683823 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11543732 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 11543732 |
| D008070 | Lipopolysaccharides | Ginkgo biloba extract 761 inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 11543732 |
| D008070 | Lipopolysaccharides | [Glycyrrhizic Acid co-treated with Lipopolysaccharides] results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|increases activity | 11412311 |
| D008070 | Lipopolysaccharides | honokiol analog inhibits the reaction [Lipopolysaccharides results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 19539808 |
| D008070 | Lipopolysaccharides | IL10 protein inhibits the reaction [Lipopolysaccharides results in increased activity of and results in increased localization of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10814840 |
| D008070 | Lipopolysaccharides | IL10 protein inhibits the reaction [[Lipopolysaccharides results in increased activity of NFKB1 protein] which results in increased expression of IL6 protein] | decreases reaction|increases activity|increases expression | 10814840 |
| D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides affects the localization of and results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|affects reaction|increases activity | 11123339 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the localization of and results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects localization|increases activity | 11123339 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the localization of and results in increased activity of [RELA protein binds to NFKB1 protein] | affects binding|affects localization|increases activity | 17855110 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the localization of and results in increased expression of NFKB1 protein | affects localization|increases expression | 10755711 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the localization of NFKB1 protein | affects localization | 17855475 18841975 18683823 15907790 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter] | affects binding|increases reaction | 14678569 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter] | affects binding|increases reaction | 14678569 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of and results in increased localization of NFKB1 protein | increases activity|increases localization | 10814840 19159680 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of NFKB1 protein | increases activity | 17131360 18323514 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein] | affects binding|increases activity | 11543732 15896337 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 18683823 11543732 11006016 16815550 15896337 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides results in increased activity of NFKB1 protein] which results in increased expression of IL6 protein | increases activity|increases expression | 10814840 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NFKB1 mRNA | increases expression | 20423518 12057914 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 19539808 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased localization of NFKB1 protein | increases localization | 11543732 |
| D008070 | Lipopolysaccharides | Lithium inhibits the reaction [Lipopolysaccharides results in increased activity of and results in increased localization of NFKB1 protein] | decreases reaction|increases activity|increases localization | 19159680 |
| D008070 | Lipopolysaccharides | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 17855475 |
| D008070 | Lipopolysaccharides | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15064226 |
| D008070 | Lipopolysaccharides | NFKB1 protein promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CXCL9 mRNA] | affects cotreatment|increases expression|increases reaction | 15154616 |
| D008070 | Lipopolysaccharides | nonylphenol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | octachlorostyrene inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Pentachlorophenol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 20423518 |
| D008070 | Lipopolysaccharides | quercetin 3-O-(2''-galloyl)glucopyranoside inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|affects localization|decreases reaction|increases activity | 17855110 |
| D008070 | Lipopolysaccharides | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 15896337 |
| D008070 | Lipopolysaccharides | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15896337 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16171798 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18683823 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18683823 |
| D008070 | Lipopolysaccharides | Simazine inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | sinapinic acid inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18841975 |
| D008070 | Lipopolysaccharides | Ziram inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D008070 | Lipopolysaccharides | Aspirin inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 11826407 |
| D008070 | Lipopolysaccharides | broussochalcone A inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11286985 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 17887948 |
| D008070 | Lipopolysaccharides | Ethanol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 17887948 |
| D008070 | Lipopolysaccharides | Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|increases activity|increases reaction | 17887948 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides affects the localization of NFKB1 protein | affects localization | 15466358 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein | affects cotreatment|increases activity | 11826407 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of NFKB1 protein | increases activity | 11286985 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein] | affects binding|increases activity | 17887948 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein] | affects binding|increases activity | 17887948 |
| D008070 | Lipopolysaccharides | lipostabil inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 17887948 |
| D008070 | Lipopolysaccharides | puerarin inhibits the reaction [Ethanol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity | 17887948 |
| D008070 | Lipopolysaccharides | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11286985 |
| D008070 | Lipopolysaccharides | Salicylates inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 11826407 |
| C005152 | lipostabil | lipostabil inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased activity of [RELA protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity|increases reaction | 17887948 |
| C005152 | lipostabil | lipostabil inhibits the reaction [Ethanol results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 17887948 |
| D008094 | Lithium | Lithium inhibits the reaction [Lipopolysaccharides results in increased activity of and results in increased localization of NFKB1 protein] | decreases reaction|increases activity|increases localization | 19159680 |
| D008094 | Lithium | Lithium results in increased degradation of NFKB1 protein | increases degradation | 19159680 |
| D008094 | Lithium | [Lithium results in increased degradation of NFKB1 protein] inhibits the reaction [NFKB1 protein binds to MAP3K8 protein] | affects binding|decreases reaction|increases degradation | 19159680 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| D047311 | Luteolin | Luteolin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15334063 |
| D047311 | Luteolin | Luteolin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| C013592 | mangiferin | mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 15161907 |
| D008464 | Mecamylamine | Mecamylamine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| D008464 | Mecamylamine | Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| D008628 | Mercury | Mercury inhibits the reaction [lipopolysaccharide, E. coli 026-B6 results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11437639 |
| C054938 | methoctramine | methoctramine inhibits the reaction [Mevinphos affects the localization of and affects the activity of NFKB1 protein] | affects activity|affects localization|decreases reaction | 17395621 |
| C030957 | methylmercury II | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of NFKB1 mRNA | affects cotreatment|decreases expression | 17905399 |
| C008493 | methylselenic acid | methylselenic acid results in decreased expression of NFKB1 mRNA | decreases expression | 12517777 |
| D008799 | Mevinphos | methoctramine inhibits the reaction [Mevinphos affects the localization of and affects the activity of NFKB1 protein] | affects activity|affects localization|decreases reaction | 17395621 |
| D008799 | Mevinphos | Mevinphos affects the localization of and affects the activity of NFKB1 protein | affects activity|affects localization | 17395621 |
| D008799 | Mevinphos | Tropicamide inhibits the reaction [Mevinphos affects the localization of and affects the activity of NFKB1 protein] | affects activity|affects localization|decreases reaction | 17395621 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of NFKB1 mRNA | decreases expression | 19945496 |
| D009020 | Morphine | Morphine results in increased expression of NFKB1 mRNA | increases expression | 15183518 |
| C059685 | N(1),N(11)-diethylnorspermine | [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] affects the localization of NFKB1 protein | affects cotreatment|affects localization | 16637064 |
| C059685 | N(1),N(11)-diethylnorspermine | [N(1),N(11)-diethylnorspermine co-treated with Fluorouracil] results in decreased expression of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|decreases expression | 16637064 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 17407152 |
| C080418 | N-(4-O-glycerol-3-methoxybenzyl)nonivamide | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 17855475 |
| D009288 | Naproxen | Naproxen inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D009288 | Naproxen | Naproxen inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| D009496 | Neurotensin | Neurotensin results in increased activity of NFKB1 protein | increases activity | 17000667 |
| D009496 | Neurotensin | [Neurotensin results in increased activity of NFKB1 protein] which results in increased expression of IL8 mRNA | increases activity|increases expression | 17000667 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of NFKB1 mRNA | increases expression | 16780908 |
| D009569 | Nitric Oxide | NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | increases chemical synthesis|increases expression|increases reaction | 12162464 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | S-Nitroso-N-Acetylpenicillamine results in decreased expression of NFKB1 mRNA | decreases expression | 12102619 |
| C008655 | N'-nitrosonornicotine | Bungarotoxins inhibits the reaction [N'-nitrosonornicotine results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| C008655 | N'-nitrosonornicotine | Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 16835749 |
| C008655 | N'-nitrosonornicotine | N'-nitrosonornicotine results in increased expression of NFKB1 mRNA | increases expression | 16582591 16835749 |
| C025256 | nonylphenol | nonylphenol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| C014138 | octachlorostyrene | octachlorostyrene inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D019319 | Okadaic Acid | evodiamine inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| D019319 | Okadaic Acid | Fenretinide inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D019319 | Okadaic Acid | lonafarnib inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| D019319 | Okadaic Acid | Okadaic Acid inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| D019319 | Okadaic Acid | pregna-4,17-diene-3,16-dione inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| D019319 | Okadaic Acid | zerumbone inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| D010081 | Oxazolone | Oxazolone results in decreased expression of NFKB1 mRNA | decreases expression | 11379042 |
| D010100 | Oxygen | AG 1879 inhibits the reaction [Oxygen deficiency promotes the reaction [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases reaction | 17671207 |
| D010100 | Oxygen | AG 1879 inhibits the reaction [Oxygen deficiency promotes the reaction [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases reaction | 17671207 |
| D010100 | Oxygen | diphenyleneiodonium inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases reaction | 11950692 |
| D010100 | Oxygen | Oxygen deficiency promotes the reaction [NFKB1 protein binds to NFKB1 protein] | affects binding|increases reaction | 17671207 |
| D010100 | Oxygen | Oxygen deficiency promotes the reaction [NFKB1 protein binds to RELA protein] | affects binding|increases reaction | 17671207 |
| D010100 | Oxygen | Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein] | affects binding|increases reaction | 11950692 |
| D010100 | Oxygen | Rotenone inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases reaction | 11950692 |
| D010126 | Ozone | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ozone results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18207479 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]] | affects cotreatment|decreases reaction|increases activity|increases reaction | 15064226 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone results in decreased expression of IL10 protein] | decreases expression|decreases reaction | 15064226 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone results in increased expression of NOS2 protein] | decreases reaction|increases expression | 15064226 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15064226 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone results in increased expression of TNF protein] | decreases reaction|increases expression | 15064226 |
| D010126 | Ozone | NFKB1 protein promotes the reaction [[Ozone results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] | increases chemical synthesis|increases expression|increases reaction | 12162464 |
| D010126 | Ozone | Ozone results in increased activity of NFKB1 protein | increases activity | 12162464 15064226 |
| D010126 | Ozone | Ozone results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 18207479 |
| D010126 | Ozone | Ozone results in increased expression of NFKB1 protein | increases expression | 15064226 |
| D010126 | Ozone | TNF protein affects the reaction [Ozone results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects reaction|increases activity | 18207479 |
| D010126 | Ozone | wortmannin inhibits the reaction [Ozone results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18207479 |
| D010126 | Ozone | Ozone results in increased expression of NFKB1 mRNA | increases expression | 16330353 |
| D017239 | Paclitaxel | Curcumin inhibits the reaction [Paclitaxel results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16243823 |
| D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel affects the localization of and results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|affects reaction|increases activity | 11123339 |
| D017239 | Paclitaxel | Paclitaxel affects the localization of and results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects localization|increases activity | 11123339 |
| D010269 | Paraquat | NFKB1 protein mutant form inhibits the reaction [Paraquat results in increased expression of CAT mRNA] | decreases reaction|increases expression | 11728812 |
| D010269 | Paraquat | Paraquat affects the localization of [NFKB1 protein binds to RELA protein] | affects binding|affects localization | 16919916 |
| D010269 | Paraquat | Paraquat promotes the reaction [endotoxin, Escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|increases reaction | 16919916 |
| D010269 | Paraquat | Paraquat promotes the reaction [NFKB1 protein binds to NFKB1 protein] | affects binding|increases reaction | 11728812 |
| D010269 | Paraquat | Paraquat promotes the reaction [NFKB1 protein binds to RELA protein] | affects binding|increases reaction | 11728812 |
| D010269 | Paraquat | Paraquat promotes the reaction [NFKB1 protein binds to RELB protein] | affects binding|increases reaction | 11728812 |
| D010269 | Paraquat | SB 203580 inhibits the reaction [Paraquat affects the localization of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|decreases reaction | 16919916 |
| D010269 | Paraquat | SB 203580 inhibits the reaction [Paraquat promotes the reaction [endotoxin, Escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]]] | affects binding|affects localization|decreases reaction|increases reaction | 16919916 |
| C002669 | parthenolide | parthenolide inhibits the reaction [FGF2 protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16921510 |
| C002669 | parthenolide | parthenolide inhibits the reaction [Simvastatin results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 18463201 |
| C002669 | parthenolide | parthenolide inhibits the reaction [Simvastatin results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 18463201 |
| C002669 | parthenolide | parthenolide inhibits the reaction [VEGFA protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16921510 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Shiga Toxin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11675405 |
| C008776 | pelargonic acid | pelargonic acid results in decreased expression of NFKB1 mRNA | decreases expression | 11379042 |
| D010416 | Pentachlorophenol | Pentachlorophenol inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D010431 | Pentoxifylline | Pentoxifylline inhibits the reaction [Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 17952619 |
| D037342 | Pertussis Toxin | Pertussis Toxin results in increased activity of NFKB1 protein | increases activity | 16322354 |
| C076715 | pervanadate | Fenretinide inhibits the reaction [pervanadate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 20423518 |
| D010634 | Phenobarbital | Phenobarbital inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of NFKB1 protein | increases activity | 10200566 |
| D010653 | Phenylbutazone | Phenylbutazone inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D010653 | Phenylbutazone | Phenylbutazone inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| C029217 | phenyl-N-tert-butylnitrone | phenyl-N-tert-butylnitrone inhibits the reaction [Thalidomide results in decreased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases activity|decreases reaction | 14713331 |
| D010672 | Phenytoin | Phenytoin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| D010672 | Phenytoin | Phenytoin results in increased expression of NFKB1 mRNA | increases expression | 14741686 |
| D010798 | Phycocyanin | Phycocyanin inhibits the reaction [2-Acetylaminofluorene results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 17303067 |
| C121565 | pifithrin | pifithrin results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 16061640 |
| C008922 | piperine | piperine results in decreased localization of NFKB1 protein | decreases localization | 15531295 |
| C006253 | pirinixic acid | NFKB1 protein affects the susceptibility to [pirinixic acid co-treated with Diethylnitrosamine] | affects cotreatment|affects response to substance | 16434500 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NFKB1 mRNA | affects binding|decreases expression|increases activity | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of NFKB1 mRNA | decreases expression | 18249437 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 12787963 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [Hydrogen Peroxide results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [Okadaic Acid results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| D011374 | Progesterone | Mifepristone inhibits the reaction [Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D011374 | Progesterone | Progesterone inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 15866594 |
| D011411 | Propanil | Propanil inhibits the reaction [[NFKB1 protein binds to NFKB1 protein] which binds to TNF promoter] | affects binding|decreases reaction | 11312646 |
| D011411 | Propanil | Propanil inhibits the reaction [[RELA protein binds to NFKB1 protein] which binds to TNF promoter] | affects binding|decreases reaction | 11312646 |
| C107773 | pterostilbene | [pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|decreases activity | 18852136 |
| C033607 | puerarin | puerarin inhibits the reaction [Ethanol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]]] | affects binding|decreases reaction|increases activity | 17887948 |
| C033607 | puerarin | puerarin inhibits the reaction [Ethanol results in decreased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases activity|decreases reaction | 17887948 |
| C033607 | puerarin | puerarin inhibits the reaction [Ethanol results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 17887948 |
| C526689 | punarnavine | punarnavine results in decreased localization of NFKB1 protein | decreases localization | 20192578 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Hydrogen Peroxide results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 11961005 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [IL17A protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 12016129 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11739238 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Isoproterenol results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15178407 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of NFKB1 protein] | decreases reaction|increases expression | 10416616 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11286985 |
| C020972 | pyrrolidine dithiocarbamic acid | Acetylcysteine inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased activity of NFKB1 protein] | decreases activity|decreases reaction | 10661865 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid results in decreased activity of NFKB1 protein | decreases activity | 10661865 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 14527959 |
| D011794 | Quercetin | [pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|decreases activity | 18852136 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16171798 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of and results in increased activity of NFKB1 protein] | affects cotreatment|affects localization|decreases reaction|increases activity | 18090225 |
| C525669 | quercetin 3-O-(2''-galloyl)glucopyranoside | quercetin 3-O-(2''-galloyl)glucopyranoside inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|affects localization|decreases reaction|increases activity | 17855110 |
| C525669 | quercetin 3-O-(2''-galloyl)glucopyranoside | quercetin 3-O-(2''-galloyl)glucopyranoside inhibits the reaction [NFKB1 protein results in increased expression of IL6 mRNA] | decreases reaction|increases expression | 17855110 |
| C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 15896337 |
| C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15896337 |
| C009159 | rapeseed oil | rapeseed oil affects the expression of NFKB1 mRNA | affects expression | 16177195 |
| C059514 | resveratrol | [resveratrol co-treated with bortezomib] results in decreased activity of [RELA protein binds to NFKB1 protein] | affects binding|affects cotreatment|decreases activity | 17164350 |
| C059514 | resveratrol | [resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein] | affects binding|affects cotreatment|decreases activity | 17164350 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16614140 15489888 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| C059514 | resveratrol | resveratrol results in decreased activity of [RELA protein binds to NFKB1 protein] | affects binding|decreases activity | 17164350 |
| C059514 | resveratrol | resveratrol analog results in decreased expression of NFKB1 protein | decreases expression | 15652768 |
| D019438 | Ritonavir | Ritonavir results in decreased activity of NFKB1 protein | decreases activity | 16174765 |
| D012402 | Rotenone | Rotenone inhibits the reaction [Oxygen deficiency promotes the reaction [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases reaction | 11950692 |
| C423603 | RU 24858 | RU 24858 inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] | affects binding|decreases reaction|increases activity | 15963473 |
| D012459 | Salicylates | Salicylates inhibits the reaction [[Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased activity of NFKB1 protein] | affects cotreatment|decreases reaction|increases activity | 11826407 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Paraquat affects the localization of [NFKB1 protein binds to RELA protein]] | affects binding|affects localization|decreases reaction | 16919916 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Paraquat promotes the reaction [endotoxin, Escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]]] | affects binding|affects localization|decreases reaction|increases reaction | 16919916 |
| C018145 | scoparone | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NFKB1 protein] | affects localization|decreases reaction | 16376386 |
| D022621 | Shiga Toxin | PD 98059 inhibits the reaction [Shiga Toxin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11675405 |
| D022621 | Shiga Toxin | Shiga Toxin results in increased activity of NFKB1 protein | increases activity | 11675405 |
| D022621 | Shiga Toxin | Terbutaline inhibits the reaction [Shiga Toxin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11675405 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18683823 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18683823 |
| D012822 | Silicon Dioxide | NFKB1 gene SNP affects the susceptibility to Silicon Dioxide | affects response to substance | 18666137 |
| D012839 | Simazine | Simazine inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D019821 | Simvastatin | artemisinine inhibits the reaction [Simvastatin results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 18463201 |
| D019821 | Simvastatin | artemisinine inhibits the reaction [Simvastatin results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 18463201 |
| D019821 | Simvastatin | parthenolide inhibits the reaction [Simvastatin results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 18463201 |
| D019821 | Simvastatin | parthenolide inhibits the reaction [Simvastatin results in increased localization of NFKB1 protein] | decreases reaction|increases localization | 18463201 |
| D019821 | Simvastatin | RHOA protein affects the reaction [Simvastatin results in increased localization of and results in increased activity of NFKB1 protein] | affects reaction|increases activity|increases localization | 18463201 |
| D019821 | Simvastatin | Simvastatin promotes the reaction [Doxorubicin results in increased localization of and results in increased activity of NFKB1 protein] | increases activity|increases localization|increases reaction | 18463201 |
| D019821 | Simvastatin | Simvastatin promotes the reaction [Doxorubicin results in increased localization of NFKB1 protein] | increases localization|increases reaction | 18463201 |
| D019821 | Simvastatin | Simvastatin results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 18463201 |
| D019821 | Simvastatin | Simvastatin results in increased localization of NFKB1 protein | increases localization | 18463201 |
| C073734 | sinapinic acid | sinapinic acid inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18841975 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [Doxorubicin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15571967 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride affects the localization of and results in increased activity of NFKB1 protein] | affects localization|decreases reaction|increases activity | 16874658 |
| C118258 | SN50 peptide | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 18508827 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFKB1 mRNA | decreases expression | 12377979 20420878 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of NFKB1 protein | decreases expression | 20420878 |
| D018038 | Sodium Selenite | [Diethylnitrosamine co-treated with Sodium Selenite] results in increased expression of NFKB1 mRNA | affects cotreatment|increases expression | 20492335 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of NFKB1 mRNA | decreases expression | 20492335 |
| D013311 | Streptozocin | Streptozocin results in increased activity of NFKB1 protein | increases activity | 15284299 |
| D013467 | Sulindac | Sulindac inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D013467 | Sulindac | Sulindac inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| C025462 | sulindac sulfide | sulindac sulfide results in decreased activity of NFKB1 protein | decreases activity | 12085227 |
| D014284 | Triiodothyronine | Lindane affects the reaction [Triiodothyronine results in increased activity of NFKB1 protein] | affects reaction|increases activity | 15019085 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased activity of NFKB1 protein | increases activity | 15019085 |
| D016559 | Tacrolimus | Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18172886 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15489888 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 15489888 |
| C001803 | tempol | tempol inhibits the reaction [copper histidine results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16987042 |
| C001803 | tempol | tempol inhibits the reaction [Copper results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16987042 |
| D013726 | Terbutaline | ADRB2 protein promotes the reaction [Terbutaline results in decreased activity of NFKB1 protein] | decreases activity|increases reaction | 11675405 |
| D013726 | Terbutaline | Terbutaline inhibits the reaction [Shiga Toxin results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11675405 |
| D013726 | Terbutaline | Terbutaline results in decreased activity of NFKB1 protein | decreases activity | 11675405 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of NFKB1 mRNA | affects expression | 17107852 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of NFKB1 protein | decreases expression | 16696175 |
| D013749 | Tetrachlorodibenzodioxin | Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 17407152 |
| D013749 | Tetrachlorodibenzodioxin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFKB1 mRNA] | decreases reaction|increases expression | 17407152 |
| D013749 | Tetrachlorodibenzodioxin | NFKB1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL protein] | affects reaction|increases expression | 15972635 |
| D013749 | Tetrachlorodibenzodioxin | Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFKB1 protein] | affects localization|decreases reaction | 18172886 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the localization of NFKB1 protein | affects localization | 18172886 15972635 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of NFKB1 mRNA | decreases expression | 18684927 14708085 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NFKB1 mRNA | increases expression | 12167310 17407152 |
| D013755 | Tetradecanoylphorbol Acetate | 1'-acetoxychavicol acetate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15905586 |
| D013755 | Tetradecanoylphorbol Acetate | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| D013755 | Tetradecanoylphorbol Acetate | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| D013755 | Tetradecanoylphorbol Acetate | evodiamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15710601 |
| D013755 | Tetradecanoylphorbol Acetate | Fenretinide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 16230421 |
| D013755 | Tetradecanoylphorbol Acetate | Gliotoxin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| D013755 | Tetradecanoylphorbol Acetate | indole-3-carbinol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15811958 |
| D013755 | Tetradecanoylphorbol Acetate | lonafarnib inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15090542 |
| D013755 | Tetradecanoylphorbol Acetate | pregna-4,17-diene-3,16-dione inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 15322087 |
| D013755 | Tetradecanoylphorbol Acetate | pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 14527959 |
| D013755 | Tetradecanoylphorbol Acetate | scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NFKB1 protein] | affects localization|decreases reaction | 16376386 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate affects the localization of NFKB1 protein | affects localization | 16376386 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 9973483 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 14527959 |
| D013755 | Tetradecanoylphorbol Acetate | zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| D013755 | Tetradecanoylphorbol Acetate | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 19539808 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 19539808 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein | increases activity | 17984113 |
| D013792 | Thalidomide | [resveratrol co-treated with Thalidomide] results in decreased activity of [RELA protein binds to NFKB1 protein] | affects binding|affects cotreatment|decreases activity | 17164350 |
| D013792 | Thalidomide | phenyl-N-tert-butylnitrone inhibits the reaction [Thalidomide results in decreased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases activity|decreases reaction | 14713331 |
| D013792 | Thalidomide | Thalidomide results in decreased activity of NFKB1 protein | decreases activity | 12242718 |
| D013792 | Thalidomide | Thalidomide results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 14713331 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of NFKB1 protein | decreases expression | 16333628 |
| C024746 | tobacco tar | tobacco tar results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 15894107 |
| D014107 | Tosyllysine Chloromethyl Ketone | Tosyllysine Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 11739238 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [IL17A protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 12016129 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 10616907 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [TNF protein results in increased expression of NFKB1 protein] | decreases reaction|increases expression | 10416616 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Acetaldehyde results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 17952619 |
| D014241 | Trichloroethylene | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of NFKB1 mRNA | affects cotreatment|decreases expression | 17905399 |
| D014331 | Tropicamide | Tropicamide inhibits the reaction [Mevinphos affects the localization of and affects the activity of NFKB1 protein] | affects activity|affects localization|decreases reaction | 17395621 |
| C113580 | U 0126 | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 18508827 |
| D014635 | Valproic Acid | Valproic Acid inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased localization of and results in increased activity of NFKB1 protein] | decreases reaction|increases activity|increases localization | 10700573 |
| D014638 | Vanadates | NFKB1 protein affects the reaction [Vanadates results in increased expression of CXCL2 mRNA] | affects reaction|increases expression | 11128049 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased localization of and results in increased activity of NFKB1 protein | increases activity|increases localization | 11306435 |
| C111237 | vorinostat | [bortezomib co-treated with vorinostat] results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|affects cotreatment|decreases activity | 12893773 |
| C111237 | vorinostat | vorinostat results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 12893773 |
| C009687 | wortmannin | wortmannin inhibits the reaction [Ozone results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 18207479 |
| C451735 | WP 744 | WP 744 results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 15555623 |
| C451735 | WP 744 | WP 744 results in increased phosphorylation of NFKB1 protein | increases phosphorylation | 15555623 |
| C020174 | WR 1065 | WR 1065 results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 12007958 |
| C403304 | zerumbone | zerumbone inhibits the reaction [CHUK protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [MAP3K14 protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [TNFRSF1A protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [TRADD protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [TRAF2 protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16007145 |
| C403304 | zerumbone | zerumbone results in decreased activity of [NFKB1 protein binds to RELA protein] | affects binding|decreases activity | 16007145 |
| D015032 | Zinc | Zinc results in decreased expression of NFKB1 protein | decreases expression | 16472982 |
| D015032 | Zinc | [Zinc results in increased localization of [IKBKB protein binds to NFKBIA protein]] which results in increased expression of NFKB1 protein | affects binding|increases expression|increases localization | 17029595 |
| D015032 | Zinc | [Zinc binds to Curcumin] which affects the expression of NFKB1 mRNA | affects binding|affects expression | 19589337 |
| D015038 | Zineb | [Endosulfan co-treated with Zineb] results in increased activity of NFKB1 protein | affects cotreatment|increases activity | 17189834 |
| D015038 | Zineb | Zineb results in increased activity of NFKB1 protein | increases activity | 17189834 |
| D015039 | Ziram | Ziram inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] | decreases reaction|increases activity | 17015962 |
| D015054 | Zymosan | caffeic acid phenethyl ester inhibits the reaction [Zymosan results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 11259437 |
| D015054 | Zymosan | NFKB1 protein affects the reaction [Zymosan results in increased expression of TNF mRNA] | affects reaction|increases expression | 11259437 |
| D015054 | Zymosan | NFKB1 protein affects the reaction [Zymosan results in increased expression of TNF protein] | affects reaction|increases expression | 11259437 |
| D015054 | Zymosan | Zymosan results in increased activity of [NFKB1 protein binds to NFKB1 protein] | affects binding|increases activity | 11259437 |
| D015054 | Zymosan | Zymosan results in increased activity of [NFKB1 protein binds to RELA protein] | affects binding|increases activity | 11259437 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 8.54 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 8.54 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Carbamazepine | 28.14 | 8986270 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 28.14 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 28.14 | 17676605 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 28.14 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 28.14 | 6195326 9677735 10563481 8986270 9118846 3425630 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Terbutaline | 28.14 | 14610225 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 28.14 | 14514962 11752688 15322242 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 28.14 | 8333272 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 28.14 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | imatinib | 6.41 | 18322153 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 6.41 | 19490988 | |
| MESH:D000022 | Abortion, Spontaneous | imatinib | 4.86 | 18322153 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 6.08 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 6.08 | 11192467 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 2.59 | 17505938 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 4.25 | 9207937 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.17 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 4.06 | 17202136 17190629 16889938 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 25.85 | 17670903 15814532 12690470 | |
| MESH:D058186 | Acute Kidney Injury | Diclofenac | 25.85 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 25.85 | 17003819 16595132 16316344 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 25.85 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | Naproxen | 25.85 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 25.85 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 25.85 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 25.85 | 7897758 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 15.46 | 21297076 20525806 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 15.46 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 15.46 | 16100012 19131640 12718980 11954676 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 15.46 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 15.46 | 18653653 | |
| MESH:D000230 | Adenocarcinoma | 1,4-phenylenebis(methylene)selenocyanate | 30.51 | 12844480 | |
| MESH:D000230 | Adenocarcinoma | 9,10-Dimethyl-1,2-benzanthracene | 30.51 | 12844480 10697514 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 30.51 | 11798837 19825857 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 30.51 | 20464547 20127859 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 30.51 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 30.51 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 30.51 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 30.51 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 30.51 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 30.51 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 30.51 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 30.51 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 30.51 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 30.51 | 11910360 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 23.76 | 10737359 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 23.76 | 16176798 | |
| MESH:D000236 | Adenoma | 9,10-Dimethyl-1,2-benzanthracene | 23.76 | 11376689 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 23.76 | 6695378 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 23.76 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | Folic Acid | 23.76 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 23.76 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 23.76 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 23.76 | 10223192 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.65 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | 2-aminofluorene | 23.94 | 19052882 | |
| MESH:D018248 | Adenoma, Liver Cell | DDT | 23.94 | 12597452 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 23.94 | 19052882 17162532 17620307 19061943 18056438 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 23.94 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 23.94 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 23.94 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 9.53 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Flurbiprofen | 9.53 | 10680582 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 9.53 | 11874996 12394442 11535846 16460482 19003578 17611924 15623613 | |
| MESH:D000310 | Adrenal Gland Neoplasms | Pentachlorophenol | 8.81 | 10696769 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 8.81 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 9.30 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 9.30 | 16712894 17306315 | |
| MESH:D000382 | Agricultural Workers' Diseases | alachlor | 20.24 | 11874814 14769641 | |
| MESH:D000382 | Agricultural Workers' Diseases | DDT | 20.24 | 12584743 16487989 | |
| MESH:D000382 | Agricultural Workers' Diseases | Dicofol | 20.24 | 12584743 | |
| MESH:D000382 | Agricultural Workers' Diseases | Lindane | 20.24 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 20.24 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Simazine | 20.24 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Zineb | 20.24 | 8807224 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 3.26 | 21441931 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.96 | 15451039 15451040 | |
| MESH:D000437 | Alcoholism | Disulfiram | 6.51 | 18968458 10841824 17079463 | |
| MESH:D000437 | Alcoholism | Mecamylamine | 6.51 | 20201817 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 15.21 | 17887948 | |
| MESH:D019973 | Alcohol-Related Disorders | lipostabil | 15.21 | 17887948 | |
| MESH:D019973 | Alcohol-Related Disorders | puerarin | 15.21 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | fexofenadine | 4.51 | 16037679 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.01 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 25.47 | 15207723 17570602 14715435 | |
| MESH:D000544 | Alzheimer Disease | Copper | 25.47 | 17119284 16962711 16325427 16866297 16410023 16886094 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 25.47 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 25.47 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 25.47 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 25.47 | 17627676 15579461 | |
| MESH:D000544 | Alzheimer Disease | Lithium | 25.47 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 25.47 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 25.47 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 25.47 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 25.47 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 25.47 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 25.47 | 17119284 16410023 16325427 16580781 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 3.87 | 17688650 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 7.33 | 15469931 | |
| MESH:D000686 | Amyloidosis | Terbutaline | 7.33 | 7986221 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 7.60 | 10965797 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 7.60 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 7.60 | 16510725 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 7.76 | 9532969 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 7.76 | 16536907 14669257 | |
| MESH:D000740 | Anemia | Fluorouracil | 7.97 | 15504547 17963324 16511603 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 7.97 | 11748828 | |
| MESH:D000740 | Anemia | Zymosan | 7.97 | 18664788 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.23 | 14761424 11369114 17661222 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.01 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 3.67 | 16614410 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.61 | 16916123 | |
| MESH:D000787 | Angina Pectoris | Diltiazem | 5.23 | 15929820 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.49 | 10982225 | |
| MESH:D000853 | Anophthalmos | Benomyl | 8.07 | 15907663 | |
| MESH:D000853 | Anophthalmos | Ethanol | 8.07 | 15513904 | |
| MESH:D000860 | Anoxia | Oxygen | 3.73 | 20872349 | |
| MESH:D001008 | Anxiety Disorders | Diazepam | 8.44 | 16284244 18313124 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 8.44 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 8.44 | 17497229 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.56 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 7.36 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 7.36 | 10388637 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.31 | 12569548 16251483 18414634 16835338 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 6.01 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 6.01 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.81 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 19.36 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 19.36 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 19.36 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 19.36 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 19.36 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 19.36 | 18706406 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 19.36 | 15142272 17659584 15944321 16872482 15188379 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 4.11 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 4.11 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 4.11 | 15570426 | |
| MESH:D001249 | Asthma | Acetaldehyde | 4.24 | 9600491 | |
| MESH:D001249 | Asthma | Ozone | 4.24 | 16373670 17854713 | |
| MESH:D001249 | Asthma | Zinc | 4.24 | 17085522 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 3.53 | 20485159 12372130 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 3.64 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 16.12 | 17363696 16037261 16126721 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 16.12 | 12928151 19371607 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 16.12 | 18704882 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 16.12 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 16.12 | 16391483 | |
| MESH:D050197 | Atherosclerosis | Phenytoin | 16.12 | 15136057 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 16.12 | 16873680 17967414 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 2.99 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 2.99 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 2.99 | 16917939 18929414 19056591 19267885 | |
| MESH:D001321 | Autistic Disorder | Mercury | 2.99 | 17497416 | |
| MESH:D001321 | Autistic Disorder | Sirolimus | 2.99 | 21115397 | |
| MESH:D001321 | Autistic Disorder | Terbutaline | 2.99 | 16417856 17400887 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 2.99 | 18985861 19460635 18558336 18396377 15238991 17157402 20603192 18775368 17507914 16609825 18940202 17688650 18177632 18316065 19232924 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 10.65 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Mercury | 10.65 | 16634805 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 10.65 | 19761891 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.67 | 10684365 | |
| MESH:D001714 | Bipolar Disorder | Carbamazepine | 6.88 | 20046352 17594078 | |
| MESH:D001714 | Bipolar Disorder | Lithium | 6.88 | 20338123 19153942 20046352 17594078 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 6.88 | 20046352 17594078 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 11.97 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 11.97 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 11.97 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 11.97 | 12125929 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.44 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 4.59 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 4.59 | 8888407 | |
| MESH:D001851 | Bone Diseases, Metabolic | Ginkgo biloba extract 761 | 5.00 | 19356626 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.87 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 12.68 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 12.68 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 12.68 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | imatinib | 6.79 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 6.79 | 15867366 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 5.79 | 11985600 | |
| MESH:D001862 | Bone Resorption | mangiferin | 5.79 | 9881647 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 4.00 | 11207687 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 3.87 | 6740701 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.67 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.98 | 17868700 | |
| MESH:D001930 | Brain Injuries | Progesterone | 6.71 | 15845082 15665606 15380490 | |
| MESH:D001930 | Brain Injuries | Zinc | 6.71 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 27.68 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 27.68 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 27.68 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Morphine | 27.68 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 27.68 | 16041641 | |
| MESH:D002545 | Brain Ischemia | puerarin | 27.68 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 27.68 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 14.69 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Copper | 14.69 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 14.69 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 14.69 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 14.69 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | 4-hydroxyestradiol-17 beta | 45.93 | 16675129 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 45.93 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 45.93 | 17127718 16153821 18840765 15565634 20435547 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 45.93 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 45.93 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 45.93 | 11921183 17162533 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 45.93 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 45.93 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 45.93 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Copper | 45.93 | 15986119 17079463 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 45.93 | 18462866 18593918 16243823 19250217 | |
| MESH:D001943 | Breast Neoplasms | DDT | 45.93 | 12709520 16792888 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 45.93 | 19208741 18320071 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 45.93 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 45.93 | 17129689 15324884 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 45.93 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 45.93 | 18382427 15567936 15939500 17983394 18695136 18234424 16264153 16826403 18628466 15993339 15994142 17426702 15136595 15692762 19526202 16322301 17369602 16096432 15668708 16595493 15634643 16935488 11325840 16115903 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 45.93 | 12948864 17018787 17289903 16675129 19861407 17261762 14630087 18497071 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 45.93 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 45.93 | 15136595 18608205 19217205 18357371 16557594 16595493 16110121 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 45.93 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 45.93 | 16873071 17200150 16541309 | |
| MESH:D001943 | Breast Neoplasms | gingerol | 45.93 | 17683926 | |
| MESH:D001943 | Breast Neoplasms | imatinib | 45.93 | 17614352 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 45.93 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 45.93 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | Lindane | 45.93 | 14688026 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 45.93 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 45.93 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 45.93 | 18323546 16115903 15136595 18234424 16244791 18223236 16273361 11325840 | |
| MESH:D001943 | Breast Neoplasms | parthenolide | 45.93 | 16873071 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 45.93 | 17614352 15562024 16175315 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 45.93 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 45.93 | 16393696 17651959 17534123 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 45.93 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 45.93 | 21138602 19155303 19289846 18629630 21152245 17893378 19066611 19189210 19487384 15668708 20065188 19011961 19410462 20859285 19244106 18351453 16273361 19142967 18984771 20544844 20135344 16202921 19103187 19221464 17049068 19115204 20005174 19189212 20390343 15565566 18997820 19084267 18821012 18815881 16818667 16873071 17242785 18855134 18425577 17440819 19059307 19200415 11161223 19288272 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 45.93 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Trichloroethylene | 45.93 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | vorinostat | 45.93 | 16144943 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 2.56 | 19059883 15516495 14754758 18315731 16777450 18417511 17626835 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.06 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 7.04 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 7.04 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.98 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 13.49 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 13.49 | 15625704 16537180 15141370 11239499 | |
| MESH:D002100 | Cachexia | Ozone | 13.49 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.18 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.52 | 15325261 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.13 | 16111702 | |
| MESH:D019559 | Capillary Leak Syndrome | Terbutaline | 4.51 | 9428835 11713377 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 6.31 | 3786805 15700767 16124888 16192424 16097048 16227642 16011737 15721981 18705752 15673190 10355542 16050911 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Pentoxifylline | 6.31 | 16227642 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 13.47 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 13.47 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 13.47 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 10.67 | 18593918 | |
| MESH:D002277 | Carcinoma | Disulfiram | 10.67 | 17026967 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 10.67 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 10.67 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.65 | 17687452 15504454 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.19 | 19066611 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 56.40 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 56.40 | 3084413 6705139 3581430 10737359 17761372 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-aminofluorene | 56.40 | 19052882 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 56.40 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 56.40 | 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 56.40 | 15073043 14691202 15553829 16217749 11135700 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 56.40 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 56.40 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | DDT | 56.40 | 12597452 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 56.40 | 16502159 19418558 19701751 17428255 17173139 18494052 18393292 19107877 17761372 19383236 17978847 18056438 19171122 10737359 20524982 19394651 19208518 19822196 16878318 20935162 18506893 10672840 20007298 20512989 18788625 20432363 20727157 16807293 20514400 16935385 17138121 16681979 3084413 16540662 19539802 17055752 16288022 3581430 16328049 16698587 19052882 18978308 18210153 16779866 21159647 20214788 20084675 18691550 17162532 16569478 18971187 19519916 19919837 18785209 16830150 11831363 18665156 20101231 19335982 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 56.40 | 16924424 15948411 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 56.40 | 17876044 18059187 16023760 16234567 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 56.40 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 56.40 | 15289165 15763234 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 56.40 | 16270382 17159502 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 56.40 | 17045692 17971768 16332177 16799960 18930000 17088986 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 56.40 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 56.40 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 56.40 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 56.40 | 6705139 17173139 20935162 20007298 1701930 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 56.40 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 56.40 | 12508355 19519916 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 56.40 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Sirolimus | 56.40 | 19335982 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 56.40 | 15276417 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 56.40 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 56.40 | 16313753 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.65 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | ginsenoside Rg3 | 11.69 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 11.69 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 11.69 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.01 | 18791128 11352223 14736730 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 14.15 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 14.15 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 14.15 | 12023789 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 14.15 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 14.15 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 14.15 | 17290066 15496427 16230376 18347146 19233551 20005069 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 14.15 | 12391285 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.64 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.52 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 8.28 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 8.28 | 1485588 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 8.28 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 8.28 | 17341418 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.90 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | 9,10-Dimethyl-1,2-benzanthracene | 41.23 | 11376689 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 41.23 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 41.23 | 15504454 17687452 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 41.23 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 41.23 | 17066447 6189445 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 41.23 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 41.23 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 41.23 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 41.23 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 41.23 | 16757204 16280240 18986760 17066447 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 41.23 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 41.23 | 12636206 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 41.23 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Sirolimus | 41.23 | 19435901 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 41.23 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 41.23 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 41.23 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 9.07 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 9.07 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 9.07 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Copper | 14.57 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 14.57 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 14.57 | 11179087 7544033 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 14.57 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 14.57 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 14.57 | 18670907 16120746 18850075 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.53 | 16612575 17308081 16242529 16278810 16455267 16364871 17928571 17974986 17382496 15505089 15792986 17924179 17007740 16269455 15811867 18627295 16952015 17351982 17519947 17131338 15476868 16109756 16651473 17329180 16731534 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 5.12 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 3.78 | 16243910 17334414 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Mercury | 3.78 | 10334427 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 18.08 | 15738583 17938729 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 18.08 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 18.08 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 18.08 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 18.08 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Tacrolimus | 18.08 | 17703430 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 18.08 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.11 | 16973168 18022660 | |
| MESH:D002386 | Cataract | Acetaminophen | 7.01 | 10977129 | |
| MESH:D002386 | Cataract | Disulfiram | 7.01 | 17936468 15003327 | |
| MESH:D002386 | Cataract | Simvastatin | 7.01 | 12518039 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 25.73 | 6135515 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4-hydroxyestradiol-17 beta | 25.73 | 18566989 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 25.73 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 25.73 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 25.73 | 1399818 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 25.73 | 7505956 17174075 21159647 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 25.73 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 25.73 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 25.73 | 19524636 20056578 | |
| MESH:D002471 | Cell Transformation, Neoplastic | tobacco tar | 25.73 | 19559774 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 7.33 | 4080065 | |
| MESH:D002493 | Central Nervous System Diseases | Phenytoin | 7.33 | 4080065 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 4.14 | 16154183 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 2.03 | 20734317 | |
| MESH:D018281 | Cholangiocarcinoma | 2-aminofluorene | 13.47 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 13.47 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 13.47 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 13.47 | 18291259 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.81 | 11181007 | |
| MESH:D002779 | Cholestasis | Diosgenin | 10.37 | 16105132 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 10.37 | 17681005 17110522 16105132 11677210 16919318 17333356 15861022 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 10.37 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 10.37 | 19176532 | |
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 4.53 | 11748493 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.43 | 15894690 | |
| MESH:D002971 | Cleft Lip | Ethanol | 7.24 | 15513904 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 7.24 | 21254359 | |
| MESH:D002971 | Cleft Lip | Phenytoin | 7.24 | 2227380 | |
| MESH:D002972 | Cleft Palate | Diazepam | 9.95 | 3629520 | |
| MESH:D002972 | Cleft Palate | Ethanol | 9.95 | 15513904 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 9.95 | 8946559 21254359 | |
| MESH:D002972 | Cleft Palate | Phenytoin | 9.95 | 3877104 2227380 6862529 6856622 1687470 10789828 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 9.95 | 15668235 8697196 12621046 15340226 16354765 | |
| MESH:D019970 | Cocaine-Related Disorders | Cocaine | 8.28 | 19606084 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 8.28 | 19462300 | |
| MESH:D003092 | Colitis | Amiloride | 12.44 | 12065299 | |
| MESH:D003092 | Colitis | Curcumin | 12.44 | 16782535 18200517 16804969 | |
| MESH:D003092 | Colitis | resveratrol | 12.44 | 16474422 | |
| MESH:D003092 | Colitis | Thalidomide | 12.44 | 16680017 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 3.00 | 20423518 | |
| MESH:D003103 | Coloboma | Curcumin | 7.20 | 18809619 | |
| MESH:D003103 | Coloboma | Phenytoin | 7.20 | 9212184 | |
| MESH:D003110 | Colonic Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 34.36 | 10753194 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 34.36 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 34.36 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 34.36 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 34.36 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 34.36 | 16343908 17510524 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 34.36 | 16340194 19359593 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 34.36 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Deoxycholic Acid | 34.36 | 16213893 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 34.36 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 34.36 | 17725105 17172411 15001691 16340194 16510598 17016597 17169374 18772588 17287894 17018589 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 34.36 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 34.36 | 11260862 15625704 15936596 15786552 15637740 15963497 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 34.36 | 17287894 17725105 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 34.36 | 15741050 11134977 19056647 16640504 19440933 17191121 17148506 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 34.36 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 34.36 | 12458338 12902858 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 25.95 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 25.95 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 25.95 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 25.95 | 11197048 18349538 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 25.95 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 25.95 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 25.95 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 25.95 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 25.95 | 16524972 17016601 17454858 18949393 17401013 17255274 16303861 18448328 18509181 16282729 20501625 18288408 16331619 15289873 18802399 17594712 15148649 14970324 17094418 17695437 18383874 16391804 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 25.95 | 17245555 16985020 16963246 17116713 17087956 | |
| MESH:D015179 | Colorectal Neoplasms | gefitinib | 25.95 | 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 25.95 | 17054584 12606626 18059344 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 25.95 | 16391804 18509181 15273666 17159606 16303861 17454858 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 25.95 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | pterostilbene | 25.95 | 18852136 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 25.95 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 25.95 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 25.95 | 11197048 10666051 18059344 11076880 | |
| MESH:D003128 | Coma | Ginkgo biloba extract 761 | 4.87 | 10836866 | |
| MESH:D000013 | Congenital Abnormalities | DDT | 8.88 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Phenytoin | 8.88 | 10627286 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 8.88 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 8.25 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 8.25 | 9301478 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.74 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.90 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.36 | 17302372 | |
| MESH:D003371 | Cough | Terbutaline | 4.23 | 19679606 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.94 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 16.99 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 16.99 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Carbamazepine | 16.99 | 9014606 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 16.99 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 16.99 | 15513904 15451039 11873399 19302082 10194807 11198716 15451040 | |
| MESH:D019465 | Craniofacial Abnormalities | imatinib | 16.99 | 18322153 | |
| MESH:D019465 | Craniofacial Abnormalities | Lead | 16.99 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | lead acetate | 16.99 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 16.99 | 19952982 9212184 8986270 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 16.99 | 15322242 10048152 20055451 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 16.99 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 16.99 | 16575769 17688650 8888407 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 16.99 | 19302082 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.31 | 16078585 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.27 | 12952375 16002989 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.50 | 16547730 | |
| MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 11.69 | 18551238 | |
| MESH:D003490 | Cyanosis | Endosulfan | 11.69 | 7900959 | |
| MESH:D003490 | Cyanosis | Propanil | 11.69 | 4714336 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 7.77 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 7.77 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Simvastatin | 7.77 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 4.05 | 12161096 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 8.79 | 16733453 | |
| MESH:D007644 | Darier Disease | Lithium | 8.79 | 20338123 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.84 | 15213294 | |
| MESH:D003704 | Dementia | Lead | 4.03 | 16140633 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.62 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.05 | 19031437 | |
| MESH:D003872 | Dermatitis | Benzene | 3.46 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | alachlor | 11.07 | 8428444 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 11.07 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 11.07 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Mercury | 11.07 | 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 11.07 | 16780908 16823706 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Zineb | 11.07 | 8807224 | |
| MESH:D003876 | Dermatitis, Atopic | fexofenadine | 4.38 | 17133778 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 4.38 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | Oxazolone | 3.86 | 15944321 12811023 | |
| MESH:D009783 | Dermatitis, Occupational | Zineb | 5.16 | 8807224 | |
| MESH:D018500 | Diabetes Insipidus, Nephrogenic | Lithium | 4.43 | 19244398 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 8.73 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 8.73 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 8.73 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 10.46 | 12093613 19028559 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 10.46 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 10.46 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 10.46 | 16684804 6379147 15862027 1374869 19496084 12644472 2177838 8740154 18603373 12093613 19960420 19298542 12446591 19586609 15831366 15298345 7637645 17442507 16286809 17874149 18715473 11260395 11055810 12083368 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 3.04 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | marker/mechanism | 17107852 | ||
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 13.92 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 13.92 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 13.92 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 13.92 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 13.92 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 13.92 | 11315760 9881663 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 13.92 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 13.92 | 17107852 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.39 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 24.17 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 24.17 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 24.17 | 19960420 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 24.17 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 24.17 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 24.17 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 24.17 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.18 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 7.99 | 17662242 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 7.99 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 8.84 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 8.84 | 7907874 7237001 | |
| MESH:D003967 | Diarrhea | Morphine | 8.84 | 2540324 | |
| MESH:D003967 | Diarrhea | vorinostat | 8.84 | 20479100 | |
| OMIM:607208 | DRAVET SYNDROME | Carbamazepine | 8.06 | 11748493 | |
| OMIM:607208 | DRAVET SYNDROME | Phenytoin | 8.06 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Phenytoin | 4.19 | 15024534 | |
| MESH:D004342 | Drug Hypersensitivity | Carbamazepine | 3.42 | 15057820 16538175 20216337 16538176 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 35.18 | 21346803 18551238 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 35.18 | 17522070 19416960 17562736 11287661 15619225 11461765 12958197 10915739 19370779 14986274 16485898 16109766 11421492 16081117 19420014 18713872 11529661 15968718 12392966 11834606 19164858 19739265 16393943 19085960 2444490 18071297 19923254 16781746 12540782 12705907 11739529 16177239 12594235 17906064 14550746 16227642 10663392 14725611 11743745 12153990 10774834 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 35.18 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbamazepine | 35.18 | 17465707 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 35.18 | 17522070 3732212 10915739 3786805 11566570 10092053 21278145 19336974 15998439 7179309 7440962 15027814 2869522 7120509 16177239 6884620 4309450 6623471 15968718 9327722 16227642 19085960 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 35.18 | 17851650 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chloroform | 35.18 | 6623471 7440962 3732212 7120509 3104120 17522070 6884620 2862719 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 35.18 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 35.18 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 35.18 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | gadolinium chloride | 35.18 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | Gliotoxin | 35.18 | 19739265 | |
| MESH:D056486 | Drug-Induced Liver Injury | Pentoxifylline | 35.18 | 16227642 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ritonavir | 35.18 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 35.18 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 35.18 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Trichloroethylene | 35.18 | 7120509 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 35.18 | 1733752 19641884 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 8.85 | 19426721 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Glycyrrhizic Acid | 8.85 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Carbamazepine | 10.64 | 20216337 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 10.64 | 15033597 12649298 12231392 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 10.64 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 10.64 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 8.81 | 18446180 16133044 18450898 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 8.81 | 16133044 18043480 17190690 18446180 12774134 16326151 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 8.26 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 8.26 | 17151854 11595431 17045617 17351913 11535926 16699067 17329845 10671773 11991626 17202747 11595415 | |
| MESH:D004381 | Duodenal Ulcer | Tacrolimus | 8.26 | 17202747 | |
| MESH:D050171 | Dyslipidemias | Clofibrate | 2.99 | 16707586 | |
| MESH:D004417 | Dyspnea | DDT | 9.81 | 16487989 | |
| MESH:D004417 | Dyspnea | Endosulfan | 9.81 | 3388749 7900959 | |
| MESH:D004417 | Dyspnea | Oxygen | 9.81 | 20016425 | |
| MESH:D004421 | Dystonia | Diazepam | 10.64 | 1851702 | |
| MESH:D004421 | Dystonia | Phenobarbital | 10.64 | 1851702 | |
| MESH:D004421 | Dystonia | Valproic Acid | 10.64 | 1851702 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.18 | 12438553 | |
| MESH:D004487 | Edema | Aspirin | 41.32 | 17259670 | |
| MESH:D004487 | Edema | bisindolylmaleimide I | 41.32 | 8273558 | |
| MESH:D004487 | Edema | Cimetidine | 41.32 | 19703484 | |
| MESH:D004487 | Edema | Dexamethasone | 41.32 | 19703484 | |
| MESH:D004487 | Edema | Diclofenac | 41.32 | 16273134 | |
| MESH:D004487 | Edema | imatinib | 41.32 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 41.32 | 7907874 10653021 16100529 7990266 8273558 19703484 8985016 | |
| MESH:D004487 | Edema | Phenylbutazone | 41.32 | 8985016 | |
| MESH:D004487 | Edema | pirinixic acid | 41.32 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 41.32 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 41.32 | 8985016 | |
| MESH:D004487 | Edema | sinapinic acid | 41.32 | 18841975 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 41.32 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 41.32 | 11698051 8113982 9599246 7812673 16716910 8273558 15177302 | |
| MESH:D004487 | Edema | Zymosan | 41.32 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 2.55 | 15322242 18230668 16714409 | |
| MESH:D004646 | Emphysema | Endosulfan | 5.19 | 7900959 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 23.86 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Carbamazepine | 23.86 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 23.86 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 23.86 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 23.86 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 23.86 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 23.86 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 3.76 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 7.48 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 7.48 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 15.83 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 15.83 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 15.83 | 19148513 18566989 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 15.83 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 15.83 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 15.83 | 19155303 16202921 20544844 17893378 | |
| MESH:D004715 | Endometriosis | celecoxib | 29.33 | 15652904 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 29.33 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 29.33 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 29.33 | 16134523 | |
| MESH:D004715 | Endometriosis | Naproxen | 29.33 | 15652904 | |
| MESH:D004715 | Endometriosis | Progesterone | 29.33 | 16134523 | |
| MESH:D004715 | Endometriosis | Sulindac | 29.33 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 29.33 | 9294722 10568697 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 9.57 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 9.57 | 15268973 | |
| MESH:D019446 | Endotoxemia | endotoxin, Escherichia coli | 23.98 | 17637181 18509659 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 23.98 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 23.98 | 18509659 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, E. coli 026-B6 | 23.98 | 8368378 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 23.98 | 12954792 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 23.98 | 17637181 15328337 15821434 | |
| MESH:D004751 | Enteritis | Clonidine | 7.58 | 8982514 | |
| MESH:D004751 | Enteritis | Indomethacin | 7.58 | 16328016 10567023 17763956 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 8.02 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 8.02 | 17923197 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 2.81 | 11298111 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Carbamazepine | 7.46 | 19915237 16538176 16415921 18855540 20485159 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 7.46 | 20235791 | |
| MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 4.87 | 1399206 6251365 | |
| MESH:D004831 | Epilepsies, Myoclonic | Carbamazepine | 10.96 | 17275665 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 10.96 | 3659116 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 10.96 | 17275665 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Carbamazepine | 17.55 | 17116037 16628512 15008574 | |
| MESH:D004828 | Epilepsies, Partial | Diazepam | 17.55 | 3922381 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 17.55 | 3922381 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Phenytoin | 17.55 | 17116037 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 17.55 | 16628512 3922381 | |
| MESH:D004827 | Epilepsy | Carbamazepine | 14.09 | 18234410 821787 17178248 19700373 7988514 19620853 9014606 19439326 17465707 20417680 | |
| MESH:D004827 | Epilepsy | Diazepam | 14.09 | 821787 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 14.09 | 20417680 | |
| MESH:D004827 | Epilepsy | Phenytoin | 14.09 | 11434505 20417680 821787 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 14.09 | 19439326 19700373 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 14.09 | 18234410 20417680 | |
| MESH:D004832 | Epilepsy, Absence | Diazepam | 8.25 | 6401628 6426943 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 8.25 | 6401628 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 8.25 | 6426943 6254150 7562514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Carbamazepine | 17.25 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 17.25 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 17.25 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 17.25 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Carbamazepine | 14.72 | 3659116 15276670 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 14.72 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 14.72 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 14.72 | 3659116 | |
| MESH:D004916 | Erythromelalgia | Carbamazepine | 4.38 | 19549232 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.76 | 16302075 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 16.58 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 16.58 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 16.58 | 15173087 16481741 17638652 16785472 15464296 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 16.58 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 16.58 | 16337965 17638652 15173087 16785472 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 16.58 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 16.58 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 16.58 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 16.58 | 16543248 | |
| MESH:D020329 | Essential Tremor | Lead | 4.59 | 18007985 14594619 | |
| MESH:D005076 | Exanthema | Carbamazepine | 4.14 | 20485159 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 4.15 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Benomyl | 5.76 | 1914497 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 5.76 | 11564622 | |
| MESH:D005221 | Fatigue | vorinostat | 4.26 | 20479100 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 42.45 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 42.45 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 42.45 | 12631006 61145 12795759 19224547 15959796 16239168 17595544 16045604 | |
| MESH:D005234 | Fatty Liver | Clofibrate | 42.45 | 19224547 | |
| MESH:D005234 | Fatty Liver | Curcumin | 42.45 | 19297423 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 42.45 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Ethanol | 42.45 | 18620774 19236843 16409862 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 42.45 | 15345470 | |
| MESH:D005234 | Fatty Liver | mangiferin | 42.45 | 15975614 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 42.45 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 42.45 | 15975614 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 42.45 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 42.45 | 14986274 19224547 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.30 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.87 | 16002989 16513791 16534752 15751030 16611131 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.87 | 16709447 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.96 | 16946407 15451040 15513904 10194807 | |
| MESH:D005313 | Fetal Death | Phenytoin | 6.41 | 10627286 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 6.41 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.53 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Lead | 11.17 | 19769572 | |
| MESH:D005317 | Fetal Growth Retardation | lead acetate | 11.17 | 19769572 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 11.17 | 8888407 18558336 | |
| MESH:D005334 | Fever | endotoxin, Escherichia coli | 15.75 | 16997862 | |
| MESH:D005334 | Fever | Ibuprofen | 15.75 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 15.75 | 10431976 11852909 17627676 | |
| MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 15.75 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 15.75 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 8.53 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 8.53 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 17.28 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | imatinib | 17.28 | 17453242 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 17.28 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 17.28 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 3.56 | 10962813 | |
| MESH:D005355 | Fibrosis | arsenite | 22.09 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 22.09 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 22.09 | 18705752 | |
| MESH:D005355 | Fibrosis | Indomethacin | 22.09 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 22.09 | 19474275 | |
| MESH:D005355 | Fibrosis | Terbutaline | 22.09 | 15467267 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 22.09 | 20067830 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.81 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.20 | 6392382 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.97 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 3.87 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 21.98 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 21.98 | 15046732 | |
| MESH:D005756 | Gastritis | Folic Acid | 21.98 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 21.98 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 21.98 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.73 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.39 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 8.39 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 8.39 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.94 | 12701121 | |
| MESH:D005885 | Gingival Hyperplasia | Phenytoin | 4.33 | 9029455 | |
| MESH:D019214 | Gingival Overgrowth | Phenytoin | 4.87 | 16390469 14659971 | |
| MESH:D005901 | Glaucoma | Folic Acid | 3.81 | 16504073 | |
| MESH:D005909 | Glioblastoma | Aspirin | 21.34 | 12870263 | |
| MESH:D005909 | Glioblastoma | Curcumin | 21.34 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 21.34 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 21.34 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 21.34 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 21.34 | 12870263 | |
| MESH:D005909 | Glioblastoma | Okadaic Acid | 21.34 | 17312396 | |
| MESH:D005909 | Glioblastoma | Quercetin | 21.34 | 19804834 | |
| MESH:D005910 | Glioma | Fluorouracil | 7.63 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 7.63 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Quercetin | 7.63 | 17643826 | |
| MESH:D005910 | Glioma | Thalidomide | 7.63 | 16327979 | |
| MESH:D005911 | Gliosis | Paraquat | 3.81 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.87 | 16524712 15173396 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.13 | 11849393 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.23 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.01 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Tacrolimus | 4.56 | 16376943 | |
| MESH:D006130 | Growth Disorders | Amiloride | 8.40 | 19703807 | |
| MESH:D006130 | Growth Disorders | Tacrolimus | 8.40 | 11041285 | |
| MESH:D006130 | Growth Disorders | Zinc | 8.40 | 17217573 | |
| MESH:D006261 | Headache | Aspirin | 6.84 | 15240983 | |
| MESH:D006261 | Headache | Nitric Oxide | 6.84 | 11554966 11284996 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 20.37 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 20.37 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 20.37 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 20.37 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 20.37 | 15102660 15162350 18337622 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 20.37 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Sirolimus | 20.37 | 19435901 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 3.11 | 19898482 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.24 | 15464296 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 8.47 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 8.47 | 17286298 16524890 | |
| MESH:D006330 | Heart Defects, Congenital | Lithium | 8.47 | 19638421 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 8.47 | 11294989 10048152 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 9.54 | 16330681 17875725 16144979 18006777 16244371 14766674 18674790 16879835 17888722 16495754 16707910 16244372 12587719 | |
| MESH:D006331 | Heart Diseases | mangiferin | 9.54 | 12093613 | |
| MESH:D006331 | Heart Diseases | pifithrin | 9.54 | 14766674 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 9.54 | 12093613 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 11.65 | 17481944 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 11.65 | 18097624 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 11.65 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 11.65 | 18097624 | |
| MESH:D006333 | Heart Failure | Zinc | 11.65 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.41 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 3.28 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 3.96 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 8.39 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 8.39 | 15692506 | |
| MESH:D006394 | Hemangiosarcoma | Pentachlorophenol | 8.39 | 15200160 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 3.39 | 16183116 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.17 | 16366002 | |
| MESH:D006470 | Hemorrhage | Endosulfan | 6.34 | 7900959 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 6.34 | 11000095 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.33 | 15633222 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 8.65 | 19900420 19110552 | |
| MESH:D006505 | Hepatitis | DDT | 8.65 | 16487989 | |
| MESH:D006505 | Hepatitis | Zymosan | 8.65 | 19110552 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.40 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 7.61 | 17338147 | |
| MESH:D006521 | Hepatitis, Chronic | Diclofenac | 7.61 | 14986274 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 7.05 | 17109627 16607473 19888908 17276780 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 7.05 | 17276780 | |
| MESH:D006529 | Hepatomegaly | DDT | 13.71 | 2387028 | |
| MESH:D006529 | Hepatomegaly | Dicofol | 13.71 | 2387028 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 13.71 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 13.71 | 18467677 16221962 19772884 19176532 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 13.71 | 16120746 12621046 15340226 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.72 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.41 | 7520565 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.67 | 15709030 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 9.05 | 10715843 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 9.05 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 9.05 | 16876885 | |
| MESH:D051677 | Histiocytoma, Malignant Fibrous | 1-nitropyrene | 5.85 | 6692400 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 4.44 | 12878215 | |
| MESH:D015658 | HIV Infections | Ritonavir | 4.44 | 17378895 11363243 15388451 11141242 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 4.15 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 5.67 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 5.67 | 15147373 17606976 18501091 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 5.67 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 5.90 | 17088409 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 5.90 | 17454163 16566672 14716179 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.53 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.69 | 15340226 18606429 8697196 16354765 16959395 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.40 | 15240983 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 6.60 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 6.60 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 6.60 | 12727271 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.36 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.19 | 16899240 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 4.21 | 18089816 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 5.32 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 5.32 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.30 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 8.30 | 11156591 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 5.23 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 5.23 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Carbamazepine | 12.40 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 12.40 | 16865747 16395265 16755160 16433478 16397167 | |
| MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 12.40 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 12.40 | 16484555 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 3.83 | 9881663 11315760 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.23 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 11.93 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 11.93 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 11.93 | 15975614 15268973 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 11.93 | 16873680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | Simvastatin | 4.07 | 16238680 | |
| MESH:D006965 | Hyperplasia | Carbamazepine | 6.97 | 18773962 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 6.97 | 12960047 14722030 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 8.07 | 17604070 | |
| MESH:D006967 | Hypersensitivity | fexofenadine | 8.07 | 17910814 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 8.07 | 16536907 | |
| MESH:D006973 | Hypertension | Amiloride | 10.56 | 15174897 18524855 19344079 | |
| MESH:D006973 | Hypertension | Arsenic | 10.56 | 9931084 16076760 11953799 | |
| MESH:D006973 | Hypertension | Benzene | 10.56 | 17940673 | |
| MESH:D006973 | Hypertension | Dexamethasone | 10.56 | 17042910 | |
| MESH:D006973 | Hypertension | Quercetin | 10.56 | 18356687 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 10.56 | 18850075 18670907 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.78 | 15338365 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Clonidine | 4.85 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | gefitinib | 5.31 | 18424623 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 5.31 | 15838368 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 10.86 | 16672835 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 10.86 | 12791704 | |
| MESH:D006984 | Hypertrophy | Sirolimus | 10.86 | 19211884 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.09 | 17488730 | |
| MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 4.89 | 18424623 | |
| MESH:D006985 | Hyperventilation | Terbutaline | 4.75 | 10895896 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.20 | 16093927 | |
| MESH:D007008 | Hypokalemia | Terbutaline | 4.75 | 17292646 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 4.51 | 19822448 | |
| MESH:C537153 | Hypomagnesemia primary | Tacrolimus | 4.82 | 11041285 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.90 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.90 | 16945680 16569931 | |
| MESH:D007022 | Hypotension | Isoflurane | 8.46 | 12967683 | |
| MESH:D007022 | Hypotension | Isoproterenol | 8.46 | 6740701 | |
| MESH:D007022 | Hypotension | Tacrolimus | 8.46 | 11041285 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.67 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.01 | 10651667 16133968 10647630 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 4.50 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 9.70 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 9.70 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 12.01 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 12.01 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 12.01 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 7.26 | 15036965 | |
| MESH:D007246 | Infertility | Ziram | 7.26 | 6420938 | |
| MESH:D007247 | Infertility, Female | Dicofol | 6.47 | 11762692 10631594 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 6.47 | 12013081 | |
| MESH:D007248 | Infertility, Male | alachlor | 22.61 | 17049205 12948887 16466525 | |
| MESH:D007248 | Infertility, Male | Coumestrol | 22.61 | 16892005 | |
| MESH:D007248 | Infertility, Male | DDT | 22.61 | 17157474 17192596 | |
| MESH:D007248 | Infertility, Male | decitabine | 22.61 | 17581917 | |
| MESH:D007248 | Infertility, Male | Endosulfan | 22.61 | 8588293 9432128 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 22.61 | 17937319 | |
| MESH:D007248 | Infertility, Male | Lead | 22.61 | 16780224 | |
| MESH:D007248 | Infertility, Male | Paraquat | 22.61 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 22.61 | 12646999 15346721 | |
| MESH:D007249 | Inflammation | Amiloride | 58.53 | 17237260 | |
| MESH:D007249 | Inflammation | bisindolylmaleimide I | 58.53 | 8273558 | |
| MESH:D007249 | Inflammation | Curcumin | 58.53 | 18403477 16956363 17151092 | |
| MESH:D007249 | Inflammation | Dexamethasone | 58.53 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diclofenac | 58.53 | 16273134 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 58.53 | 18785209 | |
| MESH:D007249 | Inflammation | ethylisopropylamiloride | 58.53 | 17237260 | |
| MESH:D007249 | Inflammation | Flurbiprofen | 58.53 | 11099482 | |
| MESH:D007249 | Inflammation | honokiol | 58.53 | 19539808 | |
| MESH:D007249 | Inflammation | Ibuprofen | 58.53 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 58.53 | 7812673 3291741 12568917 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 58.53 | 17237260 9205823 12878042 17963957 17255318 | |
| MESH:D007249 | Inflammation | mangiferin | 58.53 | 15222974 | |
| MESH:D007249 | Inflammation | Naproxen | 58.53 | 3291741 | |
| MESH:D007249 | Inflammation | Plant Extracts | 58.53 | 19332304 16366677 12787963 15997105 | |
| MESH:D007249 | Inflammation | Progesterone | 58.53 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 58.53 | 16366677 | |
| MESH:D007249 | Inflammation | Sulindac | 58.53 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 58.53 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 58.53 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 58.53 | 8273558 11698051 7562506 15177302 7812673 | |
| MESH:D007249 | Inflammation | Thalidomide | 58.53 | 16134734 | |
| MESH:D007249 | Inflammation | Zymosan | 58.53 | 11289658 8014878 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.48 | 18200517 18596194 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 11.11 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 11.11 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 11.11 | 16624496 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 12.32 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 12.32 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 12.32 | 11315760 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 12.32 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 12.32 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 6.02 | 15610444 15831440 10210152 11713966 11686837 17329856 18236018 11855677 17994277 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 6.02 | 11713966 11574821 10210152 | |
| MESH:D007414 | Intestinal Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 17.88 | 10753194 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 17.88 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 17.88 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 17.88 | 12351151 12584176 12628509 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 17.88 | 12351151 12663524 10213222 12584176 10223192 12628509 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.72 | 11245490 12394442 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.01 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 3.36 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.50 | 17553498 | |
| MESH:D007511 | Ischemia | mangiferin | 6.91 | 16806951 | |
| MESH:D007511 | Ischemia | Zinc | 6.91 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 6.01 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 6.01 | 16580747 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.67 | 16133968 18306037 10574470 | |
| MESH:D007627 | Keloid | Quercetin | 3.64 | 17086741 | |
| MESH:D007642 | Keratosis | Arsenic | 3.65 | 16930632 12749816 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.78 | 15464296 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 40.77 | 12587719 15629191 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 40.77 | 12488133 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 40.77 | 15369732 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 40.77 | 12649298 18289764 15190930 19839026 12231392 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 40.77 | 16775033 15369732 15699352 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 40.77 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 40.77 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 40.77 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Mercury | 40.77 | 17934191 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 40.77 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 40.77 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 40.77 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Tacrolimus | 40.77 | 11041285 | |
| MESH:D007674 | Kidney Diseases | tempol | 40.77 | 17640563 | |
| MESH:D007674 | Kidney Diseases | Zinc | 40.77 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 13.85 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 13.85 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 13.85 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 13.85 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 14.40 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 14.40 | 15003126 16762066 14681315 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 14.40 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 14.40 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | gefitinib | 14.40 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 14.40 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.45 | 11231351 | |
| MESH:D007855 | Lead Poisoning | Lead | 4.59 | 16700817 | |
| MESH:D007859 | Learning Disorders | Copper | 25.25 | 17134702 | |
| MESH:D007859 | Learning Disorders | DDT | 25.25 | 7589230 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 25.25 | 17184923 | |
| MESH:D007859 | Learning Disorders | Endosulfan | 25.25 | 8157075 | |
| MESH:D007859 | Learning Disorders | Ethanol | 25.25 | 15451040 | |
| MESH:D007859 | Learning Disorders | Lead | 25.25 | 16384672 | |
| MESH:D007859 | Learning Disorders | mangiferin | 25.25 | 19182383 | |
| MESH:D007889 | Leiomyoma | Curcumin | 3.31 | 18555241 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 3.50 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 5.36 | 12228301 10320625 11703811 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Pentoxifylline | 5.36 | 16863518 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Pentoxifylline | 4.80 | 11508396 | |
| MESH:D007898 | Leishmaniasis, Visceral | artemisinine | 5.22 | 20403680 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 5.22 | 16514283 | |
| MESH:D053609 | Lethargy | Terbutaline | 4.96 | 10895896 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 22.62 | 12970779 | |
| MESH:D007938 | Leukemia | alachlor | 22.62 | 14769641 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 22.62 | 15070760 | |
| MESH:D007938 | Leukemia | Benzene | 22.62 | 18335105 17119257 14694614 15935818 | |
| MESH:D007938 | Leukemia | Curcumin | 22.62 | 18462866 | |
| MESH:D007938 | Leukemia | decitabine | 22.62 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | Genistein | 22.62 | 18980019 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 22.62 | 17468513 | |
| MESH:D007938 | Leukemia | SN50 peptide | 22.62 | 12970779 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.80 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 4.95 | 17026967 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | honokiol | 4.95 | 15802533 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 13.24 | 17077332 12560223 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 13.24 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 13.24 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Ritonavir | 13.24 | 16174765 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 12.03 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 12.03 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 12.03 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 11.06 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | imatinib | 11.06 | 15748426 17301526 15107311 19208803 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 11.06 | 10785260 15631656 16572323 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 11.06 | 15498116 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 12.87 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 12.87 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 12.87 | 18454857 19117987 17236224 | |
| MESH:D007951 | Leukemia, Myeloid | imatinib | 12.87 | 17236224 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 10.09 | 17050201 19850784 16467208 20471514 16968895 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 10.09 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 10.09 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 10.09 | 18460780 17679729 18704418 19387464 19010910 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 10.09 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 10.09 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 10.09 | 16294345 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 4.10 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 9.75 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 9.75 | 12712474 19225113 19642359 11161223 17712046 15336539 15213294 12679006 15622746 11468182 17649720 12018890 19035177 17107899 9834237 16966277 16823087 17869043 16891316 17217047 19075265 16331271 15748426 16112521 16330433 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 9.75 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 9.75 | 16087638 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.44 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.44 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 4.01 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.36 | 17980183 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 3.37 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.68 | 16707609 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.65 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 7.75 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 7.75 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 7.75 | 10473037 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 2.11 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.55 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.36 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 20.22 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 20.22 | 11408273 17157831 17334410 16943688 21278145 16239168 11903743 16221502 17174718 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 20.22 | 18522880 18407596 20032147 18665156 19638242 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 20.22 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 20.22 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 20.22 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | puerarin | 20.22 | 16426832 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 20.22 | 17174718 16943688 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.76 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | marker/mechanism | 21399635 | ||
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 3.22 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | 1,3-dimethylthiourea | 34.08 | 11682029 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 34.08 | 10355542 14716496 12632514 14620537 15362042 12898905 11481614 17557913 15996030 15818738 15730626 18006644 16011737 17761835 12632512 15925388 15650968 15931870 15338365 17698563 14724832 17922224 18205269 12649538 18279442 12389079 16116963 12666154 13678700 17823541 15123356 14512876 15673190 17708605 15876570 15370692 12609069 16097048 18339082 16136751 16192424 12546737 12586293 16638106 14716833 17900296 18418968 17481882 18420326 17869086 18166357 14748882 18705752 18251166 16027843 18376398 12741479 15052691 12667390 16033810 17766677 18395914 17640975 18412020 20821823 18472332 17805973 12445418 12445421 16015684 17721639 18277467 15893842 18054572 18263696 17714472 18429990 18472094 12958196 18481824 17976157 18317297 18187930 16248980 18395095 18156304 17631135 17565644 15057751 17944888 15959796 17525996 18210741 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | cis-9, trans-11-conjugated linoleic acid | 34.08 | 17869086 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 34.08 | 17355460 18705752 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 34.08 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 34.08 | 16439617 16595196 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 34.08 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 34.08 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | gadolinium chloride | 34.08 | 12666154 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 34.08 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | imatinib | 34.08 | 16596278 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 34.08 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 34.08 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Pentoxifylline | 34.08 | 16703270 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 34.08 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 34.08 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 34.08 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 34.08 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Sirolimus | 34.08 | 17050028 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 34.08 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 34.08 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 34.08 | 15465738 | |
| MESH:D008107 | Liver Diseases | therapeutic | 15743782 | ||
| MESH:D008107 | Liver Diseases | Acetaminophen | 29.98 | 12587719 16611625 16610002 12969438 11587558 19460945 19014921 19784758 | |
| MESH:D008107 | Liver Diseases | Arsenic | 29.98 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 29.98 | 15830285 16246199 16964402 17285989 15720792 | |
| MESH:D008107 | Liver Diseases | Curcumin | 29.98 | 16956363 | |
| MESH:D008107 | Liver Diseases | DDT | 29.98 | 15729006 | |
| MESH:D008107 | Liver Diseases | Diclofenac | 29.98 | 16867024 14566034 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 29.98 | 17034775 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 29.98 | 16877991 | |
| MESH:D008107 | Liver Diseases | limonene | 29.98 | 1715830 | |
| MESH:D008107 | Liver Diseases | Lindane | 29.98 | 1715830 | |
| MESH:D008107 | Liver Diseases | Naproxen | 29.98 | 16867024 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 29.98 | 19363144 | |
| MESH:D008107 | Liver Diseases | Phenytoin | 29.98 | 14986274 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 29.98 | 17034775 | |
| MESH:D008107 | Liver Diseases | Sulindac | 29.98 | 16867024 14986274 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 3.35 | 17347304 17207112 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 2.86 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 5.38 | 16871587 17185352 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 5.38 | 14706259 16899240 | |
| MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 71.67 | 16835634 18644402 | |
| MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 71.67 | 7678174 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 71.67 | 14678523 10672840 16273603 11376686 18001218 10737359 | |
| MESH:D008113 | Liver Neoplasms | 2-aminofluorene | 71.67 | 19499222 20492335 20452335 19850985 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 71.67 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 71.67 | 9643874 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 71.67 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 71.67 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 71.67 | 20195826 21137059 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 71.67 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 71.67 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Copper | 71.67 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | DDT | 71.67 | 15975961 11948501 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 71.67 | 12112319 2422723 19690152 21071580 20137499 19996281 20452335 19090486 18648771 21047994 21278145 15885732 19812893 19850985 19294768 20405173 19638242 18977376 15175105 2862719 19254457 20583210 19499222 9163691 18644402 19833225 19427195 20434301 16942905 19642983 19426721 19255062 18754104 18978307 20101389 20118626 12771043 19073162 20501860 21167192 19551842 20492335 19256749 10737359 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 71.67 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 71.67 | 17045692 18383874 16603448 15113037 | |
| MESH:D008113 | Liver Neoplasms | Glycyrrhizic Acid | 71.67 | 19426721 | |
| MESH:D008113 | Liver Neoplasms | Pentachlorophenol | 71.67 | 10696769 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 71.67 | 21047994 19073162 19482888 8742319 19812893 15975961 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 71.67 | 20007298 16377806 15890375 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 71.67 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 71.67 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 71.67 | 19073162 19812893 19321006 20405173 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 71.67 | 16712894 15276417 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 71.67 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 71.67 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 71.67 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 31.29 | 6135515 2876786 2876784 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 31.29 | 534488 6150874 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 31.29 | 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 31.29 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 31.29 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 31.29 | 15583823 12014681 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Deoxycholic Acid | 31.29 | 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 31.29 | 19009564 18308698 18253720 19519916 18079962 18282651 18544905 17174075 19539802 3124819 18775883 17942915 19126423 21159647 16267830 16842330 18164116 18093689 17854601 19004024 2563599 9362446 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 31.29 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 31.29 | 1399818 2563599 17172636 6150874 18308698 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 31.29 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 31.29 | 12151625 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Trichloroethylene | 31.29 | 7955063 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.27 | 15213294 | |
| MESH:D008171 | Lung Diseases | 2-chloroethyl ethyl sulfide | 12.11 | 18675330 12815614 16252256 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 12.11 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 12.11 | 11504702 | |
| MESH:D008171 | Lung Diseases | Ozone | 12.11 | 8266340 19066396 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 12.11 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 6.92 | 14698565 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 6.92 | 17228818 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 22.76 | 17365036 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 22.76 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 22.76 | 11395602 | |
| MESH:D055370 | Lung Injury | Oxygen | 22.76 | 18339021 | |
| MESH:D055370 | Lung Injury | Ozone | 22.76 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 22.76 | 16129981 | |
| MESH:D055370 | Lung Injury | S-methylisothiopseudouronium | 22.76 | 18573544 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 48.84 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 48.84 | 16401635 9255578 14755239 18813816 18508827 15172992 17139156 12438228 19931552 16061637 15893417 | |
| MESH:D008175 | Lung Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 48.84 | 11376689 | |
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 48.84 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 48.84 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 48.84 | 17976673 19168569 17306315 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 48.84 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 48.84 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 48.84 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 48.84 | 20869020 17053015 18816296 18520028 20464547 6695378 20064080 20135361 18569708 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 48.84 | 11696405 19925653 11246140 18597497 16337739 19359593 15390079 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 48.84 | 17225452 11798837 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 48.84 | 19359593 18462866 16243823 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 48.84 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 48.84 | 21163286 20970405 6695378 20512841 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 48.84 | 6189445 17418594 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 48.84 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 48.84 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 48.84 | 18520028 18816296 18569708 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 48.84 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 48.84 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 48.84 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 48.84 | 17306315 17077188 16712894 19931552 15276417 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 48.84 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 48.84 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 48.84 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 48.84 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Vehicle Emissions | 48.84 | 9255578 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.45 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Carbamazepine | 5.16 | 16628512 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 5.16 | 17718048 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Silicon Dioxide | 5.16 | 16373255 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.81 | 15166399 | |
| MESH:D008223 | Lymphoma | 9,10-Dimethyl-1,2-benzanthracene | 26.31 | 11376689 | |
| MESH:D008223 | Lymphoma | Benzene | 26.31 | 17584886 17119257 | |
| MESH:D008223 | Lymphoma | bortezomib | 26.31 | 16098063 | |
| MESH:D008223 | Lymphoma | Curcumin | 26.31 | 18462866 | |
| MESH:D008223 | Lymphoma | decitabine | 26.31 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 26.31 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 26.31 | 16098063 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 26.31 | 16166326 | |
| MESH:D008223 | Lymphoma | Pentachlorophenol | 26.31 | 12669308 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 10.06 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 10.06 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 10.06 | 14737004 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 7.92 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 7.92 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 7.92 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 12.09 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 12.09 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 12.09 | 15621674 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.37 | 20479100 | |
| MESH:D008288 | Malaria | artemisinine | 4.34 | 16919048 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.15 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 9.22 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 9.22 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 9.22 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1,4-phenylenebis(methylene)selenocyanate | 45.42 | 12844480 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1-nitropyrene | 45.42 | 6692400 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 45.42 | 8985016 11807958 16082771 16153821 18840765 1500032 12844480 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 45.42 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 45.42 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 45.42 | 19196722 12104042 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 45.42 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 45.42 | 17203775 11807958 11408345 16891317 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 45.42 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 45.42 | 18375820 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 45.42 | 12929590 14578162 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 45.42 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 45.42 | 11408345 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 45.42 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 45.42 | 19196723 11731420 19196722 14580682 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 45.42 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 45.42 | 12773700 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 8.16 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 8.16 | 19453300 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 4.35 | 16832597 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 3.49 | 19213072 | |
| MESH:D008545 | Melanoma | Carboplatin | 25.07 | 16225601 11712820 16342250 12040289 | |
| MESH:D008545 | Melanoma | Cisplatin | 25.07 | 11135225 15577323 12393984 18176117 12374674 18505091 18332650 17023156 12883367 17761969 16248763 16432458 16809738 | |
| MESH:D008545 | Melanoma | Curcumin | 25.07 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | decitabine | 25.07 | 16505122 17785578 | |
| MESH:D008545 | Melanoma | Disulfiram | 25.07 | 15367699 | |
| MESH:D008545 | Melanoma | Doxorubicin | 25.07 | 16827129 | |
| MESH:D008545 | Melanoma | Fenretinide | 25.07 | 16270382 | |
| MESH:D008545 | Melanoma | Glucose | 25.07 | 14993021 | |
| MESH:D008545 | Melanoma | Paclitaxel | 25.07 | 12025231 16342250 12040289 | |
| MESH:D008545 | Melanoma | resveratrol | 25.07 | 17992120 | |
| MESH:D008545 | Melanoma | Sirolimus | 25.07 | 19282848 | |
| MESH:D008545 | Melanoma | sodium arsenite | 25.07 | 19082730 16487513 | |
| MESH:D008545 | Melanoma | Sulindac | 25.07 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 25.07 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Thalidomide | 25.07 | 16098027 17089043 12829675 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 7.10 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 7.10 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 6.65 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 6.65 | 10803710 | |
| MESH:D008569 | Memory Disorders | Curcumin | 12.44 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 12.44 | 15451040 18411066 | |
| MESH:D008569 | Memory Disorders | Lead | 12.44 | 17263510 16384672 | |
| MESH:D008569 | Memory Disorders | mangiferin | 12.44 | 19182383 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.54 | 17268249 17109627 | |
| MESH:D008607 | Mental Retardation | Carbamazepine | 4.15 | 9014606 | |
| MESH:D008607 | Mental Retardation | Phenytoin | 4.15 | 9212184 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 5.68 | 16966607 16166281 18303189 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 5.68 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 5.68 | 17638057 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 3.14 | 17112576 | |
| MESH:D008679 | Metaplasia | Ozone | 3.75 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | Propanil | 4.53 | 2315934 2237922 4714336 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 12.16 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 12.16 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Naproxen | 12.16 | 18803445 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 12.16 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 12.16 | 18765137 18803445 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 3.84 | 14659530 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.25 | 15792986 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 15.09 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 15.09 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 15.09 | 18986760 16757204 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 15.09 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Sirolimus | 15.09 | 19435901 | |
| MESH:D052016 | Mucositis | Doxorubicin | 8.00 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 8.00 | 17159606 | |
| MESH:D009101 | Multiple Myeloma | alachlor | 36.50 | 14769641 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 36.50 | 19549372 19417148 14977855 15949261 11468182 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 36.50 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 36.50 | 19372569 19112817 19112201 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 36.50 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 36.50 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 36.50 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 36.50 | 15867202 16118317 15744524 | |
| MESH:D009101 | Multiple Myeloma | lonafarnib | 36.50 | 16996129 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 36.50 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 36.50 | 17049120 17164350 16490592 17935668 14749477 16267019 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 36.50 | 15744524 19112201 15741222 15867202 17168659 19372569 15920492 19112817 16445831 15939924 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.95 | 10479408 17724436 18160304 15834315 12130978 12879239 15259001 15213630 15241586 10890648 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 7.99 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 7.99 | 17962980 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 2.21 | 16239165 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 2.79 | 8888407 | |
| MESH:D009164 | Mycobacterium Infections | Ritonavir | 4.44 | 21442799 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.32 | 18349030 | |
| MESH:D015878 | Mydriasis | Tropicamide | 5.99 | 16308726 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 16.32 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 16.32 | 19010910 16882708 19157545 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 16.32 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Pentoxifylline | 16.32 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 16.32 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 16.32 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 30.80 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 30.80 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Cocaine | 30.80 | 18072171 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 30.80 | 15857846 19429709 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 30.80 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 30.80 | 19595682 16538859 19172585 16584858 15740881 16697266 17052832 | |
| MESH:D009203 | Myocardial Infarction | Lithium | 30.80 | 16288908 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 30.80 | 19172585 16584858 16538859 16697266 17052832 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 30.80 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 30.80 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 30.80 | 16317513 17188708 17125593 16525036 16456233 17015251 | |
| MESH:D009203 | Myocardial Infarction | S-methylisothiopseudouronium | 30.80 | 10090345 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 8.66 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 8.66 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 8.66 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 11.10 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 11.10 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 11.10 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 11.10 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.43 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 8.07 | 17484760 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 8.07 | 17484760 | |
| MESH:D009224 | Myotonia Congenita | Carbamazepine | 8.07 | 20399394 | |
| MESH:D009224 | Myotonia Congenita | Phenytoin | 8.07 | 1896199 | |
| MESH:D009325 | Nausea | Aspirin | 7.75 | 15240983 | |
| MESH:D009325 | Nausea | vorinostat | 7.75 | 20479100 | |
| MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 2.55 | 18551238 7678174 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 14.31 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 14.31 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 14.31 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 14.31 | 18047805 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 27.83 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 27.83 | 3581430 9029167 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 27.83 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 27.83 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | imatinib | 27.83 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 27.83 | 16537180 11239499 11053908 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 27.83 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 27.83 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Pentoxifylline | 27.83 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | punarnavine | 27.83 | 19171408 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 27.83 | 19393235 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.88 | 19410462 | |
| MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 38.51 | 8820588 | |
| MESH:D009369 | Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 38.51 | 11544531 | |
| MESH:D009369 | Neoplasms | Acrolein | 38.51 | 17329238 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 38.51 | 11141357 | |
| MESH:D009369 | Neoplasms | Carboplatin | 38.51 | 17925555 18854779 | |
| MESH:D009369 | Neoplasms | Cisplatin | 38.51 | 16773208 | |
| MESH:D009369 | Neoplasms | DDT | 38.51 | 8820588 | |
| MESH:D009369 | Neoplasms | decitabine | 38.51 | 19116145 19470736 17925555 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 38.51 | 15313581 | |
| MESH:D009369 | Neoplasms | Disulfiram | 38.51 | 17079463 | |
| MESH:D009369 | Neoplasms | Fenretinide | 38.51 | 17353921 15958647 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 38.51 | 16928823 18600527 18239605 | |
| MESH:D009369 | Neoplasms | Lindane | 38.51 | 12807735 16818664 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 38.51 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 38.51 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 38.51 | 11559025 | |
| MESH:D009369 | Neoplasms | Trichloroethylene | 38.51 | 11911487 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 7.93 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 7.93 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 7.93 | 20056578 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 15.27 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 15.27 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | imatinib | 15.27 | 17614352 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 15.27 | 19189210 19196722 19200415 | |
| MESH:D018301 | Neoplasms, Mesothelial | Pentachlorophenol | 5.29 | 10696769 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 17.97 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 17.97 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 17.97 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 17.97 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | parthenolide | 17.97 | 16921510 | |
| MESH:D009393 | Nephritis | Acrolein | 4.93 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 6.47 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 6.47 | 6375363 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.45 | 16636307 16899518 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 2.82 | 16889571 15640375 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 10.90 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 10.90 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 10.90 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 10.90 | 18619942 17356569 15790535 | |
| MESH:D009422 | Nervous System Diseases | Dicofol | 4.50 | 1856875 | |
| MESH:D009421 | Nervous System Malformations | Benomyl | 32.08 | 14502586 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 32.08 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Carbamazepine | 32.08 | 16990009 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 32.08 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 32.08 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 32.08 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 32.08 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 32.08 | 16859833 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.27 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 22.19 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 22.19 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 22.19 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 22.19 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 22.19 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | Phenytoin | 22.19 | 9118846 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 22.19 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 22.19 | 8888407 16359493 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.87 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 8.84 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 8.84 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 8.84 | 8761367 | |
| MESH:D009447 | Neuroblastoma | WP 744 | 8.84 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 21.94 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 21.94 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 21.94 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 21.94 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 21.94 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 21.94 | 16850258 17266991 | |
| MESH:D019636 | Neurodegenerative Diseases | Tacrolimus | 21.94 | 15081597 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 11.58 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 11.58 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 11.58 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 10.56 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 10.56 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 10.56 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.76 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.34 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 4.99 | 11005259 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 4.99 | 16436463 | |
| MESH:D009503 | Neutropenia | Folic Acid | 5.98 | 16322990 | |
| MESH:D009503 | Neutropenia | Ritonavir | 5.98 | 17378895 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 3.63 | 9802331 | |
| MESH:D009669 | Nose Neoplasms | alachlor | 3.55 | 15580706 16698726 16178123 14563481 11127290 | |
| MESH:D009765 | Obesity | 2-chloroethyl ethyl sulfide | 5.69 | 16289378 | |
| MESH:D009765 | Obesity | Curcumin | 5.69 | 19297423 | |
| MESH:D009765 | Obesity | pirinixic acid | 5.69 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 5.69 | 20132043 19056576 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 8.99 | 6374098 | |
| MESH:D007752 | Obstetric Labor, Premature | Terbutaline | 8.99 | 14998686 | |
| MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 5.17 | 16049721 | |
| MESH:D009784 | Occupational Diseases | Benzene | 5.17 | 15576619 17479406 17119257 15913788 15727169 17178637 16737584 15612468 15935809 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 9.82 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Diclofenac | 9.82 | 18287210 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 9.82 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 9.82 | 7009135 | |
| MESH:D010014 | Osteolysis | imatinib | 8.01 | 15867366 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 8.01 | 15867366 | |
| MESH:D010018 | Osteomalacia | Carbamazepine | 12.69 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 12.69 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenytoin | 12.69 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 4.07 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 4.07 | 19401787 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 9.66 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 9.66 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 9.66 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 6.49 | 18047805 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 6.49 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.65 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 53.51 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 53.51 | 16891317 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 53.51 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 53.51 | 12452020 19769630 16624393 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 53.51 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 53.51 | 15464296 19769630 17225452 6897625 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 53.51 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 53.51 | 19259094 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 53.51 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 53.51 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 53.51 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 53.51 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 53.51 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 53.51 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 53.51 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 53.51 | 16525653 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 53.51 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 53.51 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 53.51 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 53.51 | 16211241 | |
| MESH:D010146 | Pain | Acetaminophen | 24.05 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 24.05 | 6363464 6995502 | |
| MESH:D010146 | Pain | Carbamazepine | 24.05 | 15215642 | |
| MESH:D010146 | Pain | Diclofenac | 24.05 | 13679232 | |
| MESH:D010146 | Pain | Ibuprofen | 24.05 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 24.05 | 17627676 13679232 3291741 17440234 | |
| MESH:D010146 | Pain | Morphine | 24.05 | 16273134 20225289 18699797 6776300 15215642 15275824 | |
| MESH:D010146 | Pain | Naproxen | 24.05 | 3291741 | |
| MESH:D010146 | Pain | Phenytoin | 24.05 | 15215642 | |
| MESH:D010146 | Pain | Sulindac | 24.05 | 3291741 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 7.02 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 7.02 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 38.55 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 38.55 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 38.55 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 38.55 | 19196508 17440100 19401701 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 38.55 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | dehydroxymethylepoxyquinomicin | 38.55 | 16211219 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 38.55 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 38.55 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 38.55 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 38.55 | 19003803 16929163 15113037 16500647 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 38.55 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 38.55 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 38.55 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 38.55 | 16820089 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 38.55 | 15976015 | |
| MESH:D010195 | Pancreatitis | artemisinine | 7.42 | 17948936 | |
| MESH:D010195 | Pancreatitis | Cimetidine | 7.42 | 10484002 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 7.42 | 17883296 15028970 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.42 | 11578682 | |
| MESH:D010212 | Papilloma | 9,10-Dimethyl-1,2-benzanthracene | 11.78 | 16517061 15173996 17234724 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 11.78 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 11.78 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 11.78 | 12065085 18404319 8330346 18922899 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.90 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.36 | 16537180 | |
| MESH:D010267 | Parapsoriasis | Carbamazepine | 4.38 | 16538176 | |
| MESH:D010291 | Paresis | Thalidomide | 4.94 | 9200351 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 10.57 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Ditiocarb | 10.57 | 11445065 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 10.57 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 10.57 | 16140633 11181820 16510128 11445065 11124998 15451049 15824117 12911755 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 10.57 | 16412576 11535288 18191903 11445065 18619942 15451049 19232380 16140633 19114014 | |
| MESH:D010300 | Parkinson Disease | Sirolimus | 10.57 | 19682553 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 3.13 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 8.60 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 8.60 | 15927086 18197244 15795934 15574749 | |
| MESH:D020734 | Parkinsonian Disorders | Tropicamide | 8.60 | 17594079 | |
| OMIM:167400 | PAROXYSMAL EXTREME PAIN DISORDER | Carbamazepine | 4.58 | 17679678 17145499 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.36 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.89 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.81 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 4.20 | 11156591 | |
| MESH:D010518 | Periodontitis | Indomethacin | 7.92 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 7.92 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 5.83 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 5.83 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 3.65 | 16905509 15371236 6392382 | |
| MESH:D010538 | Peritonitis | Isoflurane | 9.67 | 17414419 | |
| MESH:D010538 | Peritonitis | Ozone | 9.67 | 16369182 | |
| MESH:D010538 | Peritonitis | Zymosan | 9.67 | 11985352 15259001 18977430 19088179 15979727 17371808 17826846 18557954 19641140 18760300 14761945 | |
| MESH:D020795 | Photophobia | Aspirin | 4.40 | 15240983 | |
| MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 8.98 | 11550810 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 8.98 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.80 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 3.81 | 14722030 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.36 | 15687265 16977796 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 3.58 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.44 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.44 | 17638057 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 15.77 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 15.77 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 15.77 | 18007984 18929643 18381685 | |
| MESH:D011014 | Pneumonia | Paraquat | 15.77 | 12504350 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 7.90 | 18573544 | |
| MESH:D011015 | Pneumonia, Aspiration | S-methylisothiopseudouronium | 7.90 | 18573544 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Simvastatin | 4.12 | 17105841 | |
| MESH:D017689 | Polydactyly | Phenytoin | 3.84 | 9212184 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.27 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 8.52 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 8.52 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 8.52 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 7.16 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | imatinib | 7.16 | 12476293 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 7.16 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 3.05 | 17114810 | |
| MESH:D011248 | Pregnancy Complications | Carbamazepine | 3.85 | 9014606 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.81 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 25.79 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Carbamazepine | 25.79 | 9014606 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 25.79 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Lead | 25.79 | 16384672 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 25.79 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 25.79 | 11896295 11118676 11399792 11222880 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 25.79 | 20603192 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 3.41 | 17616702 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 6.43 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 6.43 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 27.70 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 27.70 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 27.70 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 27.70 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 27.70 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 27.70 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 27.70 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Coumestrol | 27.70 | 16921512 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 27.70 | 18769126 18156803 11398177 15129424 10851300 12497104 18226269 | |
| MESH:D011471 | Prostatic Neoplasms | DDT | 27.70 | 12584743 | |
| MESH:D011471 | Prostatic Neoplasms | Dicofol | 27.70 | 12584743 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 27.70 | 17136230 15046698 15846301 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 27.70 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 27.70 | 16888761 16868541 15897917 15749863 16729912 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 27.70 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 27.70 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 27.70 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | Flurbiprofen | 27.70 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | gefitinib | 27.70 | 15651060 16685379 17914592 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 27.70 | 15378649 15256057 16925846 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 27.70 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Lindane | 27.70 | 12661182 14688026 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 27.70 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 27.70 | 16729912 17136230 16356831 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | parthenolide | 27.70 | 16921510 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 27.70 | 17804756 14666653 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 27.70 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 27.70 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 27.70 | 15767336 17804756 17718901 17675339 16731767 17636462 | |
| MESH:D011471 | Prostatic Neoplasms | Simazine | 27.70 | 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 27.70 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 27.70 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 27.70 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 27.70 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | vorinostat | 27.70 | 17218635 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 27.70 | 16700911 12429649 16606632 16517595 | |
| MESH:D011507 | Proteinuria | Arsenic | 8.45 | 21343184 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 8.45 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 8.45 | 11849393 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.94 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 5.73 | 16919318 15861022 | |
| MESH:D011537 | Pruritus | fexofenadine | 5.73 | 17133778 | |
| MESH:D019310 | Pseudolymphoma | Carbamazepine | 19.91 | 9591791 12752131 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 19.91 | 12752131 | |
| MESH:D019310 | Pseudolymphoma | Phenytoin | 19.91 | 1419762 8603615 12752131 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 19.91 | 12752131 11422049 | |
| MESH:D011618 | Psychotic Disorders | Cocaine | 3.75 | 16134406 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.45 | 10548101 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 7.07 | 10903255 | |
| MESH:D011654 | Pulmonary Edema | Terbutaline | 7.07 | 10903255 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.30 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 4.64 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 6.96 | 17365031 15814490 17322281 17975199 | |
| MESH:D011658 | Pulmonary Fibrosis | gefitinib | 6.96 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 6.96 | 16324872 17997886 | |
| MESH:D011658 | Pulmonary Fibrosis | Silicon Dioxide | 6.96 | 17365031 12193738 14975940 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 5.04 | 15830843 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.82 | 18722050 16160472 18286688 15538739 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 13.91 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 13.91 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 13.91 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 13.91 | 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.22 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Morphine | 5.92 | 19211983 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 5.92 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 5.92 | 17058453 16314181 15827377 16317513 17520802 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | 2-chloroethyl ethyl sulfide | 27.88 | 16292752 12210543 18257742 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 27.88 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 27.88 | 18379247 10666014 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 27.88 | 18379247 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 27.88 | 17627322 18339021 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 27.88 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 27.88 | 16129981 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Terbutaline | 27.88 | 2878809 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.71 | 10835634 | |
| MESH:D012135 | Respiratory Sounds | alachlor | 8.94 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 8.94 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Vehicle Emissions | 8.94 | 18950799 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.54 | 18990726 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 8.68 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 8.68 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 8.68 | 16584753 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 3.42 | 16849425 | |
| MESH:D012175 | Retinoblastoma | SN50 peptide | 5.15 | 12466137 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 6.78 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 6.78 | 19155313 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 5.39 | 17050345 | |
| MESH:D012220 | Rhinitis | Aspirin | 5.39 | 12372130 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.18 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 5.56 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 5.56 | 15625365 15675481 18313854 17710206 16767912 17203757 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 14.25 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 14.25 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 14.25 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 14.25 | 14601052 16326096 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.46 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.18 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 4.16 | 9673227 | |
| MESH:D012559 | Schizophrenia | Copper | 3.28 | 16842975 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 3.28 | 16641680 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 3.28 | 15737665 19110320 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.60 | 16096327 | |
| MESH:D012640 | Seizures | 2,6-dinitrotoluene | 29.89 | 18551238 | |
| MESH:D012640 | Seizures | Carbamazepine | 29.89 | 9844417 16938433 19414003 16180713 16876388 15946322 9046859 | |
| MESH:D012640 | Seizures | Clonidine | 29.89 | 10087439 | |
| MESH:D012640 | Seizures | Cocaine | 29.89 | 10454489 | |
| MESH:D012640 | Seizures | Diazepam | 29.89 | 9754883 10087439 15946322 | |
| MESH:D012640 | Seizures | Endosulfan | 29.89 | 7539098 10698677 | |
| MESH:D012640 | Seizures | Ethanol | 29.89 | 9754883 | |
| MESH:D012640 | Seizures | Lindane | 29.89 | 15475178 7539098 12842176 | |
| MESH:D012640 | Seizures | Lithium | 29.89 | 19660546 | |
| MESH:D012640 | Seizures | Mecamylamine | 29.89 | 12660363 | |
| MESH:D012640 | Seizures | Phenobarbital | 29.89 | 3137016 11442880 4039156 16876388 | |
| MESH:D012640 | Seizures | Phenytoin | 29.89 | 3691417 11044598 19919933 15946322 16876388 10029267 9844417 3137016 | |
| MESH:D012640 | Seizures | Valproic Acid | 29.89 | 14763951 11738929 3137016 1511512 11044598 15475178 16876388 17978042 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.48 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 9.02 | 18389075 | |
| MESH:D018805 | Sepsis | Isoflurane | 9.02 | 17414419 | |
| MESH:D018805 | Sepsis | Zymosan | 9.02 | 11441115 | |
| MESH:D012772 | Shock, Septic | endotoxin, Escherichia coli | 10.70 | 18063050 | |
| MESH:D012772 | Shock, Septic | mangiferin | 10.70 | 15177305 | |
| MESH:D012772 | Shock, Septic | Terbutaline | 10.70 | 3431524 | |
| MESH:D012829 | Silicosis | Silicon Dioxide | 5.85 | 18666137 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 3.95 | 12269725 | |
| MESH:D012871 | Skin Diseases | Arsenic | 4.57 | 16702368 17548696 6392382 19834688 16759981 18709164 15952646 17050553 17938729 17453740 16353154 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 4.57 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 4.57 | 17431481 | |
| MESH:D012878 | Skin Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 40.12 | 15173996 11376689 8985016 16517061 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 40.12 | 16251483 17029826 19538983 17976673 17050553 15504454 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 40.12 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 40.12 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 40.12 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | gingerol | 40.12 | 19481070 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 40.12 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 40.12 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Okadaic Acid | 40.12 | 12628509 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 40.12 | 16517061 15173996 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 40.12 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 40.12 | 19524636 18572023 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 40.12 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 40.12 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 40.12 | 18404319 12065085 8330346 8985016 11807781 | |
| MESH:D012893 | Sleep Disorders | Carbamazepine | 3.81 | 19414003 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Clonidine | 4.40 | 18280681 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.98 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.26 | 15625365 17203757 16767912 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 12.38 | 16002989 16709447 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 12.38 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 12.38 | 16709447 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 4.15 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 6.47 | 15862959 16503802 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 6.47 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 5.76 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 5.76 | 19490988 | |
| MESH:D013160 | Splenic Neoplasms | Pentachlorophenol | 4.95 | 10696769 | |
| MESH:D013226 | Status Epilepticus | Lithium | 8.18 | 19570321 19430551 19951488 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 8.18 | 12833885 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Carbamazepine | 7.24 | 19694795 20485159 16538176 15057820 19915237 16415921 18855540 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 7.24 | 20235791 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 6.00 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 6.00 | 15038085 17638125 18209964 16280098 17207306 15472012 10215738 10192188 10486359 16184426 17160473 18545984 16113693 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 18.77 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 18.77 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 18.77 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 18.77 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 18.77 | 18396642 17522103 15958060 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 18.77 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 18.77 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 18.77 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 18.77 | 17522103 18567086 17498489 16951190 16424979 19015929 19084572 15786421 17172411 18396642 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 18.77 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | imatinib | 18.77 | 15786421 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 18.77 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 18.77 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | N'-nitrosonornicotine | 18.77 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 18.77 | 18396642 18506536 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 25.48 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 25.48 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 25.48 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 25.48 | 9562338 17918041 9211565 16755016 17189318 11906479 | |
| MESH:D013276 | Stomach Ulcer | fucoidan | 25.48 | 18209962 15138204 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 25.48 | 10423059 17654042 18087811 18726076 17977527 18193104 18431645 11595431 17627676 15255614 10750652 18181030 16631530 1323529 11729361 14567935 10878458 16252198 15104355 16169175 17135157 12467913 16150113 12498302 11906479 12787963 18299717 16934674 18543354 18237397 16397915 17918041 11595415 18209962 12077510 11145282 15138204 11523592 17895592 17657623 16755016 12500499 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 25.48 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 25.48 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 25.48 | 17135157 15255614 18193104 18237397 12787963 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 25.48 | 15138204 | |
| MESH:D020521 | Stroke | Acrolein | 8.12 | 16269634 | |
| MESH:D020521 | Stroke | Aspirin | 8.12 | 16403987 | |
| MESH:D020521 | Stroke | Folic Acid | 8.12 | 16517955 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.26 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 4.70 | 18364113 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.68 | 16045194 16684133 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Diazepam | 6.40 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 6.40 | 9754883 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 4.21 | 12563064 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 4.48 | 12837982 | |
| MESH:D013610 | Tachycardia | Terbutaline | 4.22 | 10895896 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 3.49 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 4.12 | 17997062 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 3.63 | 15864552 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.37 | 17225452 15464296 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 6.10 | 15821434 | |
| MESH:D013921 | Thrombocytopenia | vorinostat | 6.10 | 20479100 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.36 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 5.26 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 5.26 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 3.62 | 10850423 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.55 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 31.24 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | alachlor | 31.24 | 8812207 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 31.24 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 31.24 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 31.24 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 31.24 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 31.24 | 16010429 17909728 | |
| MESH:D013964 | Thyroid Neoplasms | gefitinib | 31.24 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | imatinib | 31.24 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 31.24 | 18791128 14736730 11352223 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 31.24 | 1399818 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 3.33 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 9.66 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 9.66 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 9.66 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.65 | 15213294 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 3.87 | 17262798 | |
| MESH:D014202 | Tremor | Chlordecone | 10.87 | 6175765 | |
| MESH:D014202 | Tremor | Lead | 10.87 | 21145352 | |
| MESH:D014202 | Tremor | Tropicamide | 10.87 | 17594079 19467297 | |
| MESH:D014235 | Trichinellosis | mangiferin | 4.70 | 14669257 | |
| MESH:D014402 | Tuberous Sclerosis | Sirolimus | 4.28 | 18495876 21115397 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.56 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.19 | 3119515 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 39.07 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 39.07 | 1399818 15289314 15867355 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 39.07 | 19429237 19322015 17306315 11144890 18640142 17976673 15987713 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 39.07 | 12845720 11780464 20435036 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 39.07 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 39.07 | 17225452 12973940 15464296 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 39.07 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 39.07 | 19087683 17616700 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 39.07 | 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 39.07 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 39.07 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 39.07 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 39.07 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 39.07 | 11723127 16712894 16452187 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 39.07 | 17572228 16712894 8653321 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Vehicle Emissions | 39.07 | 11144890 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.33 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.92 | 18462866 | |
| MESH:D014570 | Urologic Diseases | DDT | 4.29 | 16487989 | |
| MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 2.98 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 4.79 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 4.79 | 20485159 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 26.23 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 26.23 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 26.23 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 26.23 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 26.23 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 26.23 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 26.23 | 11813266 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 9.33 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 9.33 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 25.74 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 25.74 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 25.74 | 16690809 15809267 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 25.74 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 25.74 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 25.74 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 25.74 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 3.56 | 17785578 | |
| MESH:D014605 | Uveitis | Dexamethasone | 12.77 | 1336536 | |
| MESH:D014605 | Uveitis | Sirolimus | 12.77 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 12.77 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 6.75 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 6.75 | 16002989 16513791 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 12.61 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 12.61 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 12.61 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.23 | 12125929 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 7.57 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 7.57 | 18364113 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.30 | 15869587 14671159 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 13.91 | 17638931 16364871 17678736 17334414 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 13.91 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 13.91 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 13.91 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 8.44 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 8.44 | 18097624 | |
| MESH:D014839 | Vomiting | Cisplatin | 7.07 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 7.07 | 11897121 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.89 | 15886252 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 3.12 | 20213670 19894650 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05221 | Acute myeloid leukemia |
| KEGG:04920 | Adipocytokine signaling pathway |
| KEGG:05146 | Amoebiasis |
| KEGG:04210 | Apoptosis |
| KEGG:04662 | B cell receptor signaling pathway |
| KEGG:05142 | Chagas disease (American trypanosomiasis) |
| KEGG:04062 | Chemokine signaling pathway |
| KEGG:05220 | Chronic myeloid leukemia |
| KEGG:04623 | Cytosolic DNA-sensing pathway |
| KEGG:05120 | Epithelial cell signaling in Helicobacter pylori infection |
| KEGG:05160 | Hepatitis C |
| REACT:25035 | Innate immune response mediated by toll like receptors |
| KEGG:05140 | Leishmaniasis |
| KEGG:04010 | MAPK signaling pathway |
| KEGG:05162 | Measles |
| KEGG:04722 | Neurotrophin signaling pathway |
| KEGG:04621 | NOD-like receptor signaling pathway |
| KEGG:04380 | Osteoclast differentiation |
| KEGG:05212 | Pancreatic cancer |
| KEGG:05200 | Pathways in cancer |
| KEGG:05215 | Prostate cancer |
| KEGG:04622 | RIG-I-like receptor signaling pathway |
| KEGG:05131 | Shigellosis |
| REACT:6900 | Signaling in Immune system |
| REACT:11061 | Signalling by NGF |
| KEGG:05222 | Small cell lung cancer |
| KEGG:04660 | T cell receptor signaling pathway |
| KEGG:04620 | Toll-like receptor signaling pathway |
| KEGG:05145 | Toxoplasmosis |
| KEGG:05152 | Tuberculosis |
| Releated gene ID | Related gene Name |
|---|---|
| PA34321 | REL |
| PA30196 | KRAS |
| PA76 | BCL2L1 |
| Releated disease ID | Related disease Name |
|---|---|
| PA444485 | Hodgkin Disease |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| PA443560 | Breast Neoplasms |
| PA446108 | Colorectal Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA449412 | doxorubicin |
| PA448515 | azathioprine |
| PA450379 | mercaptopurine |
| PA449780 | glutathione |
| PA448976 | choline |
| PA448478 | l-arginine |
| PA450635 | nitric oxide |
| PA452621 | antineoplastic agents |
| PA128406956 | fluorouracil |
| PA450541 | mometasone |